<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="pmc-domain-id">3416</journal-id><journal-id journal-id-type="pmc-domain">molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12430302</article-id><article-id pub-id-type="pmcid-ver">PMC12430302.1</article-id><article-id pub-id-type="pmcaid">12430302</article-id><article-id pub-id-type="pmcaiid">12430302</article-id><article-id pub-id-type="doi">10.3390/molecules30173552</article-id><article-id pub-id-type="publisher-id">molecules-30-03552</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Synergistic Disruption of Foodborne Pathogen Biofilms by Oregano Essential Oil and Bacteriophage phiLLS: Atomic Force Microscopy Insights</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0003-4320-6391</contrib-id><name name-style="western"><surname>Kao God&#237;nez</surname><given-names initials="AK">Ana Karina</given-names></name><xref rid="af1-molecules-30-03552" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3025-0313</contrib-id><name name-style="western"><surname>Regalado-Gonz&#225;lez</surname><given-names initials="C">Carlos</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><xref rid="af2-molecules-30-03552" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3737-8416</contrib-id><name name-style="western"><surname>Villica&#241;a</surname><given-names initials="C">Claudia</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><xref rid="af3-molecules-30-03552" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1017-957X</contrib-id><name name-style="western"><surname>Heredia</surname><given-names initials="JB">Jos&#233; Basilio</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><xref rid="af1-molecules-30-03552" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9155-6981</contrib-id><name name-style="western"><surname>Valdez-Torres</surname><given-names initials="JB">Jos&#233; Benigno</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><xref rid="af1-molecules-30-03552" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6971-535X</contrib-id><name name-style="western"><surname>Muy-Rangel</surname><given-names initials="M">Mar&#237;a</given-names></name><xref rid="af1-molecules-30-03552" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Escamilla-Garc&#237;a</surname><given-names initials="M">Monserrat</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><xref rid="af2-molecules-30-03552" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3755-881X</contrib-id><name name-style="western"><surname>Le&#243;n-F&#233;lix</surname><given-names initials="J">Josefina</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><xref rid="af1-molecules-30-03552" ref-type="aff">1</xref><xref rid="c1-molecules-30-03552" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Fontana</surname><given-names initials="G">Gianfranco</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-molecules-30-03552"><label>1</label>Centro de Investigaci&#243;n en Alimentaci&#243;n y Desarrollo, A.C., Culiac&#225;n 80110, Mexico; <email>akao221@estudiantes.ciad.mx</email> (A.K.K.G.); <email>jbheredia@ciad.mx</email> (J.B.H.); <email>jvaldez@ciad.mx</email> (J.B.V.-T.); <email>mdmuy@ciad.mx</email> (M.M.-R.)</aff><aff id="af2-molecules-30-03552"><label>2</label>Facultad de Qu&#237;mica, Universidad Aut&#243;noma de Quer&#233;taro, Cerro de las Campanas, Quer&#233;taro 76010, Mexico; <email>regcarlos@gmail.com</email> (C.R.-G.); <email>monserrat.escamilla@uaq.mx</email> (M.E.-G.)</aff><aff id="af3-molecules-30-03552"><label>3</label>SECIHTI-Centro de Investigaci&#243;n en Alimentaci&#243;n y Desarrollo, A.C., Culiac&#225;n 80110, Mexico; <email>maria.villicana@ciad.mx</email></aff><author-notes><corresp id="c1-molecules-30-03552"><label>*</label>Correspondence: <email>ljosefina@ciad.mx</email></corresp></author-notes><pub-date pub-type="epub"><day>30</day><month>8</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2025</year></pub-date><volume>30</volume><issue>17</issue><issue-id pub-id-type="pmc-issue-id">496502</issue-id><elocation-id>3552</elocation-id><history><date date-type="received"><day>14</day><month>7</month><year>2025</year></date><date date-type="rev-recd"><day>23</day><month>8</month><year>2025</year></date><date date-type="accepted"><day>23</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>30</day><month>08</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>13</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-13 11:25:14.803"><day>13</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="molecules-30-03552.pdf"/><abstract><p>Foodborne pathogenic biofilms pose significant challenges to food safety due to their enhanced resistance to conventional antimicrobial agents. In this study, we evaluated the synergistic antibiofilm activity of oregano essential oil (OEO) from <italic toggle="yes">Lippia graveolens</italic> and the lytic bacteriophage phiLLS against six foodborne bacteria. GC&#8211;MS analysis achieved a 100% identification ratio, revealing that OEO was mainly composed of carvacrol (58.9%), p-cymene (28.6%), &#947;-terpinene (2.9%), and caryophyllene (2.6%). The MIC and MBC of OEO were 1 and 2 mg/mL, respectively, for all strains except <italic toggle="yes">E. coli</italic> BALL1119 (MIC = 2 mg/mL). We assessed biofilm biomass by crystal violet (CV) staining and metabolic activity using the TTC assay under both individual and combined treatments, monitored 9-hour planktonic growth kinetics to calculate Bliss and HSA synergy indexes, and employed atomic force microscopy (AFM) to visualize nanoscale alterations in <italic toggle="yes">Staphylococcus aureus</italic> and <italic toggle="yes">Escherichia coli</italic> BALL1119 biofilms. Combined OEO (2 mg/mL) and phiLLS (MOI 1) treatments achieved significantly greater biofilm biomass reduction than single agents, notably yielding &gt;70% inhibition of <italic toggle="yes">S. aureus</italic> biofilms (<italic toggle="yes">p</italic> &lt; 0.05) and a Bliss synergy index of 10.8% in <italic toggle="yes">E. coli</italic> BALL1119 growth kinetics, whereas other strains were additive. In biofilm assays, <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">Salmonella</italic> spp. showed the highest reductions in biomass (CV) (71.0% and 67.8%, &#916;HSA = 27.0% and 17.4%; &#916;Bliss = 21.1% and 13.8%) and metabolic activity (TTC) (68.6% and 48.5%). AFM revealed that OEO alone smoothed the extracellular matrix (averaging a 35% reduction in roughness), whereas the combined treatment caused fracturing (&#8776;68 nm roughness) and prominent lytic pits. Although variability in <italic toggle="yes">S. aureus</italic> biofilm architecture precluded statistically significant pairwise comparisons, AFM topography and consistent trends in Ra/Rz parameters provided clear visual corroboration of the significant reductions detected by CV and TTC assays. These complementary data indicate that OEO primes the biofilm matrix for enhanced phage-mediated collapse, offering a green, two-step strategy for controlling resilient foodborne biofilms.</p></abstract><kwd-group><kwd>atomic force microscopy</kwd><kwd>bacteriophage phiLLS</kwd><kwd>foodborne pathogens</kwd><kwd>oregano essential oil</kwd><kwd>biofilm disruption and synergy</kwd></kwd-group><funding-group><award-group><funding-source>CIAD internal project</funding-source><award-id>P00768014</award-id></award-group><award-group><funding-source>Investigadores por M&#233;xico SECIHTI project</funding-source><award-id>784</award-id></award-group><funding-statement>This research was funded by the CIAD internal project, grant number P00768014, and the Investigadores por M&#233;xico SECIHTI project number 784.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-molecules-30-03552"><title>1. Introduction</title><p>Bacterial biofilms are three-dimensional communities of cells encased in a self-produced extracellular polymeric substance (EPS) matrix that confers enhanced resistance to antimicrobials and environmental stresses compared to planktonic cells [<xref rid="B1-molecules-30-03552" ref-type="bibr">1</xref>,<xref rid="B2-molecules-30-03552" ref-type="bibr">2</xref>]. In food processing environments, biofilm-forming pathogens such as <italic toggle="yes">Escherichia coli</italic>, <italic toggle="yes">Salmonella</italic> spp., <italic toggle="yes">Listeria monocytogenes</italic>, and <italic toggle="yes">Staphylococcus aureus</italic> pose a significant threat to public health, causing persistent contamination of equipment and food surfaces [<xref rid="B3-molecules-30-03552" ref-type="bibr">3</xref>,<xref rid="B4-molecules-30-03552" ref-type="bibr">4</xref>]. Foodborne diseases remain a persistent global public health challenge, affecting millions of people annually and causing significant economic losses [<xref rid="B5-molecules-30-03552" ref-type="bibr">5</xref>,<xref rid="B6-molecules-30-03552" ref-type="bibr">6</xref>,<xref rid="B7-molecules-30-03552" ref-type="bibr">7</xref>]. According to the World Health Organization, nearly 1 in 10 people worldwide fall ill each year after consuming contaminated food, resulting in over 420,000 deaths, including approximately 125,000 deaths of children under five years old [<xref rid="B8-molecules-30-03552" ref-type="bibr">8</xref>,<xref rid="B9-molecules-30-03552" ref-type="bibr">9</xref>]. Fresh produce, in particular, has been identified as a major vehicle for pathogenic bacteria such as <italic toggle="yes">E. coli</italic> O157:H7, <italic toggle="yes">S. enterica</italic>, <italic toggle="yes">L. monocytogenes</italic>, <italic toggle="yes">S. aureus</italic>, and <italic toggle="yes">B. cereus</italic> [<xref rid="B10-molecules-30-03552" ref-type="bibr">10</xref>,<xref rid="B11-molecules-30-03552" ref-type="bibr">11</xref>]. Between 2010 and 2019, a marked increase in multistate foodborne outbreaks linked to fresh produce was reported in the United States, often associated with imported produce from Mexico and Turkey [<xref rid="B12-molecules-30-03552" ref-type="bibr">12</xref>,<xref rid="B13-molecules-30-03552" ref-type="bibr">13</xref>,<xref rid="B14-molecules-30-03552" ref-type="bibr">14</xref>].</p><p>The alarming rise of antimicrobial resistance represents one of the main challenges in controlling foodborne pathogens, exacerbated by the extensive use of antibiotics in food production [<xref rid="B9-molecules-30-03552" ref-type="bibr">9</xref>,<xref rid="B15-molecules-30-03552" ref-type="bibr">15</xref>]. Without effective interventions, resistant infections are projected to cause up to 10 million deaths annually by 2050 [<xref rid="B16-molecules-30-03552" ref-type="bibr">16</xref>]. The ability of certain pathogens to form biofilms on fresh produce and abiotic surfaces further aggravates this problem, conferring resistance up to 1000-fold higher than that of planktonic cells [<xref rid="B17-molecules-30-03552" ref-type="bibr">17</xref>,<xref rid="B18-molecules-30-03552" ref-type="bibr">18</xref>,<xref rid="B19-molecules-30-03552" ref-type="bibr">19</xref>]. These complex structures hinder eradication and promote the persistence of contamination in food processing environments.</p><p>Plant-derived essential oils (EOs) have emerged as appealing &#8220;green&#8221; antimicrobials due to their broad-spectrum activity and low toxicity. Oregano essential oil (OEO) from <italic toggle="yes">Lippia graveolens</italic>, rich in phenolic monoterpenes such as carvacrol and thymol, disrupts cell membranes and interferes with metabolic processes, significantly reducing biofilm biomass at subinhibitory concentrations [<xref rid="B20-molecules-30-03552" ref-type="bibr">20</xref>,<xref rid="B21-molecules-30-03552" ref-type="bibr">21</xref>]. However, the hydrophobic nature of EOs and the diffusional barrier imposed by the EPS matrix often limit their penetration into established biofilms [<xref rid="B3-molecules-30-03552" ref-type="bibr">3</xref>,<xref rid="B22-molecules-30-03552" ref-type="bibr">22</xref>].</p><p>Bacteriophage therapy offers high specificity and the capacity to replicate within host cells, yet standalone phage treatments can yield variable biofilm reductions depending on biofilm age, structure, and phage attributes [<xref rid="B23-molecules-30-03552" ref-type="bibr">23</xref>,<xref rid="B24-molecules-30-03552" ref-type="bibr">24</xref>]. PhiLLS, a lytic <italic toggle="yes">Siphoviridae</italic> phage isolated from wastewater in Culiac&#225;n, M&#233;xico, demonstrates a broad host range (~68% of 57 tested <italic toggle="yes">E. coli</italic> strains), a burst size of ~176 PFU/cells, a latent period of 15 min, and a &#8776;107 kb genome lacking known virulence or toxin genes, supporting its safety as a biocontrol agent [<xref rid="B25-molecules-30-03552" ref-type="bibr">25</xref>]. Phage-derived depolymerases can degrade specific components of the biofilm matrix, enhancing access to host bacteria [<xref rid="B26-molecules-30-03552" ref-type="bibr">26</xref>]. However, these enzymes alone are often insufficient for completely eradicating biofilms [<xref rid="B27-molecules-30-03552" ref-type="bibr">27</xref>]. Engineered phages expressing quorum-quenching enzymes can inhibit biofilm formation in mixed-species communities [<xref rid="B28-molecules-30-03552" ref-type="bibr">28</xref>]. Interestingly, even disintegrated phages without lytic activity can degrade biofilms, likely due to the enzymatic activities of their structural proteins [<xref rid="B14-molecules-30-03552" ref-type="bibr">14</xref>]. Genomic analysis has revealed genes encoding various enzymes that may contribute to biofilm degradation [<xref rid="B29-molecules-30-03552" ref-type="bibr">29</xref>]. Combined therapies using phages or phage-derived products with other antimicrobial agents show potential as practical approaches for biofilm removal and treatment of associated infections [<xref rid="B26-molecules-30-03552" ref-type="bibr">26</xref>,<xref rid="B27-molecules-30-03552" ref-type="bibr">27</xref>].</p><p>Recent studies suggest that combining EOs with bacteriophages can produce synergistic antibiofilm effects (fractional inhibitory concentration index &#931;FIC &#8804; 0.5), achieving greater reductions in biofilm biomass than individual treatments [<xref rid="B30-molecules-30-03552" ref-type="bibr">30</xref>]. These studies have highlighted that combining essential oils with bacteriophages not only limits bacterial growth but also impairs biofilm formation [<xref rid="B24-molecules-30-03552" ref-type="bibr">24</xref>,<xref rid="B30-molecules-30-03552" ref-type="bibr">30</xref>,<xref rid="B31-molecules-30-03552" ref-type="bibr">31</xref>]. These combined treatments have been shown to modulate the expression of virulence, adhesion, and quorum-sensing genes in pathogenic bacteria, thereby reducing their infectious potential. Biofilm eradication in these investigations is typically quantified using microtiter-plate assays. Treated biofilms are stained with 0.1% crystal violet, washed, and de-stained with ethanol, and absorbance read is at 595 nm to determine residual biomass [<xref rid="B32-molecules-30-03552" ref-type="bibr">32</xref>]. Complementary methods, such as TTC metabolic assays or CFU enumeration, help distinguish between matrix dispersal and true cell death. In this context, the Mexican oregano (<italic toggle="yes">L. graveolens</italic>) essential oil, rich in carvacrol and thymol [<xref rid="B33-molecules-30-03552" ref-type="bibr">33</xref>], and the lytic bacteriophage phiLLS [<xref rid="B25-molecules-30-03552" ref-type="bibr">25</xref>], emerge as promising candidates for a dual &#8220;green&#8221; approach to biofilm control [<xref rid="B34-molecules-30-03552" ref-type="bibr">34</xref>,<xref rid="B35-molecules-30-03552" ref-type="bibr">35</xref>].</p><p>Atomic force microscopy (AFM) provides nanoscale insights into biofilm surface topography and mechanical properties. AFM analyses of <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">Pseudomonas aeruginosa</italic> biofilms have revealed treatment-induced changes in matrix roughness and cell morphology, elucidating the physical impact of antimicrobials on EPS integrity [<xref rid="B36-molecules-30-03552" ref-type="bibr">36</xref>,<xref rid="B37-molecules-30-03552" ref-type="bibr">37</xref>].</p><p>Here, we investigate the synergistic antibiofilm activity of OEO and bacteriophage phiLLS against biofilms formed by six foodborne pathogens. It was to (i) determine the minimum inhibitory and bactericidal concentrations of OEO, (ii) quantify biofilm inhibition and eradication under solo and combined treatments using the Haney et al. microtiter assay [<xref rid="B38-molecules-30-03552" ref-type="bibr">38</xref>], (iii) monitor planktonic growth kinetics over 9 h, and (iv) employ AFM to visualize nanoscale alterations in the biofilm architecture of <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">E. coli</italic>. Our findings aim to elucidate the mechanisms driving synergy and inform the development of eco-friendly biofilm control strategies in food safety.</p></sec><sec sec-type="results" id="sec2-molecules-30-03552"><title>2. Results</title><sec id="sec2dot1-molecules-30-03552"><title>2.1. Composition of the Essential Oil</title><p>Thirteen constituents, representing 100.0% of the total oil, were identified (<xref rid="molecules-30-03552-t001" ref-type="table">Table 1</xref>). The major components were carvacrol (58.90%), p-cymene (28.62%), &#947;-terpinene (2.89%), and caryophyllene (2.59%), while the remaining compounds were present at &lt;1%.</p></sec><sec id="sec2dot2-molecules-30-03552"><title>2.2. Phage Sensitivity to OEO</title><p>The stability of phage phiLLS in oregano essential oil was assessed by incubating the phage with varying concentrations of OEO (4 mg/mL, 2 mg/mL, 1 mg/mL, 0.5 mg/mL, and ethanol at 2%). At 24 h post-incubation, there was no significant effect of OEO at concentrations of 0.5&#8211;4 mg on phage phiLLS viability.</p><p>A 10<sup>&#8722;4</sup> dilution of phiLLS was mixed with 4 mg/mL oregano essential oil (OEO) in molten soft agar and overlaid onto a bacterial lawn. The presence of numerous, well-formed plaques across the plate (titer 1.8 &#215; 10<sup>9</sup> PFU/mL) of phiLLS demonstrates that it remains fully viable at this OEO concentration and dilution, with no observable reduction in plaque count or morphology relative to OEO-free controls (<xref rid="molecules-30-03552-f001" ref-type="fig">Figure 1</xref>).</p></sec><sec id="sec2dot3-molecules-30-03552"><title>2.3. MIC and MBC Values of OEO</title><p>The antimicrobial activity of oregano essential oil (OEO) was determined against <italic toggle="yes">E. coli</italic> O157:H7, <italic toggle="yes">E. coli</italic> BALL 1119, <italic toggle="yes">Salmonella</italic> spp., <italic toggle="yes">L. monocytogenes</italic>, <italic toggle="yes">S. aureus</italic>, and <italic toggle="yes">B. cereus</italic>. OEO was tested at concentrations ranging from 4.0 to 0.025 mg/mL using the broth microdilution method. MIC values were 1 mg/mL for all strains except <italic toggle="yes">E. coli</italic> BALL 1119, which exhibited an MIC of 2 mg/mL. MBC values were consistently 2 mg/mL for all strains (<xref rid="molecules-30-03552-t002" ref-type="table">Table 2</xref>). These results guided the selection of 2 mg/mL OEO for subsequent global assays, corresponding to the MBC for all strains and the MIC for <italic toggle="yes">E. coli</italic> BALL 1119. Untreated cultures served as negative controls, and medium-only wells served as sterility controls.</p></sec><sec id="sec2dot4-molecules-30-03552"><title>2.4. Combined Application of OEO and Phage</title><sec id="sec2dot4dot1-molecules-30-03552"><title>2.4.1. Growth Kinetics: Combined vs. Individual Treatments</title><p>The growth kinetics of six foodborne pathogens under individual (OEO [2 mg/mL], phiLLS MOI 1) and combined (OEO + phiLLS) treatments were evaluated by measuring the optical density at 600 nm (OD<sub>600</sub>) over 9 h. We first compared the growth curves and derived key kinetic parameters, including specific growth rate (&#956;) and maximum density (OD<sub>max</sub>), to assess treatment efficacy. Subsequent statistical analyses (one-way ANOVA and Tukey&#8217;s HSD) identified significant differences in &#956; among treatments for each pathogen. Kinetic slope analysis for <italic toggle="yes">E. coli</italic> BALL 1119 (<xref rid="molecules-30-03552-f002" ref-type="fig">Figure 2</xref>A) shows that between 1 and 4 h, the phage treatment drives rapid initial inhibition (slope = 18.7% h<sup>&#8722;1</sup>), but its efficacy declines from 4 to 9 h (negative slope). In contrast, OEO and the combined OEO + phage treatment maintain gently positive slopes throughout the entire 1&#8211;9 h window.</p><p>The Bliss synergy index (%) at 9 h for the combined OEO + phiLLS treatment is shown in <xref rid="molecules-30-03552-f002" ref-type="fig">Figure 2</xref>B; a dashed vertical line indicates the 10% synergy threshold. In the context of growth kinetics only, dark-grey bars denote additive interactions (<italic toggle="yes">S. aureus</italic>, <italic toggle="yes">Salmonella</italic> spp., <italic toggle="yes">L. monocytogenes</italic>, <italic toggle="yes">E. coli</italic> O157:H7, and <italic toggle="yes">B. cereus</italic>, &#8804; 10%), and the green bar indicates the sole synergistic case (<italic toggle="yes">E. coli</italic> BALL 1119, 10.8%). Synergy observed here does not necessarily reflect results from biofilm assays (<xref rid="molecules-30-03552-f003" ref-type="fig">Figure 3</xref> and <xref rid="molecules-30-03552-f004" ref-type="fig">Figure 4</xref>), which are described separately below.</p></sec><sec id="sec2dot4dot2-molecules-30-03552"><title>2.4.2. Biofilm Assays</title><p>The effect of phage phiLLS in combination with OEO on preformed biofilms was quantified using biomass (CV) and metabolic activity (TTC) measurements and analyzed under the Highest Single Agent (HSA) [<xref rid="B39-molecules-30-03552" ref-type="bibr">39</xref>] and Bliss independence models [<xref rid="B40-molecules-30-03552" ref-type="bibr">40</xref>]. Across the six foodborne pathogens (<xref rid="molecules-30-03552-f003" ref-type="fig">Figure 3</xref>), the OEO + phiLLS combination significantly reduced biomass in <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">Salmonella</italic> spp. (<italic toggle="yes">p</italic> &lt; 0.05, Tukey&#8217;s HSD), achieving maximum biomass reductions of 71.0% and 67.8%, respectively, and corresponding metabolic activity reductions of 68.6% and 48.5%. Average inhibition across both endpoints was ~48% for <italic toggle="yes">S. aureus</italic> and ~44% for <italic toggle="yes">Salmonella</italic> spp.</p><p>In contrast, <italic toggle="yes">B. cereus</italic> biofilms were largely refractory, with no treatment exceeding a 50% reduction in either endpoint, and no significant differences from the control in TTC were noted. <italic toggle="yes">E. coli</italic> strains showed moderate biomass reduction (&#8804;63%) but negligible metabolic inactivation. Overall, <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">Salmonella</italic> emerged as the most susceptible species, with biomass reduction generally exceeding metabolic inactivation.</p><p>Synergy analysis (<xref rid="molecules-30-03552-f004" ref-type="fig">Figure 4</xref>) indicated convergent synergy (&#916; &gt; 10% in both HSA and Bliss) for <italic toggle="yes">L. monocytogenes</italic>, <italic toggle="yes">S. aureus</italic>, and <italic toggle="yes">Salmonella</italic> spp. in biomass reduction (CV). Only <italic toggle="yes">S. aureus</italic> exhibited synergy in metabolic inactivation (TTC). <italic toggle="yes">B. cereus</italic> showed consistent antagonism (&#916; &lt; &#8211;10%) across both models and endpoints, while <italic toggle="yes">E. coli</italic> strains fell into the additive range. Applying both HSA and Bliss models allowed complementary perspectives. HSA benchmarks the best single agent, while Bliss accounts for expected additive effects and more stringently identifies antagonism when one agent is weak.</p><p>Synergy analysis of biofilm disruption by the OEO + phiLLS combination revealed consistent synergistic effects (&#916; &gt; 10%) against <italic toggle="yes">L. monocytogenes</italic>, <italic toggle="yes">S. aureus</italic>, and <italic toggle="yes">Salmonella</italic> spp. in the CV biomass reduction assay (both HSA and Bliss models) (<xref rid="molecules-30-03552-f004" ref-type="fig">Figure 4</xref>), with <italic toggle="yes">S. aureus</italic> also exhibiting synergy in the TTC inhibition metabolic activity assay. In contrast, <italic toggle="yes">Bacillus cereus</italic> displayed clear antagonism (&#916; &lt; &#8211;10%) under both HSA and Bliss criteria in both assays, and both <italic toggle="yes">E. coli</italic> strains fell into the additive range. Bliss penalizes low phage activity more severely than HSA (<xref rid="molecules-30-03552-f004" ref-type="fig">Figure 4</xref>). Overall, synergy was relatively rare (only three of six species in CV, one in TTC), while antagonistic interactions predominated for species poorly inhibited by phage alone. These results underscore the importance of applying both HSA and Bliss models. HSA offers an intuitive comparison to the best single agent, whereas Bliss corrects for expected additive effects and more stringently flags antagonism when one agent is weak. Convergent synergy calls (e.g., for <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">Salmonella</italic>) provide high confidence in combination efficacy, whereas divergent classifications warrant further kinetic investigation or concentration optimization.</p><p>The treatments showed significantly high (77.8%) biofilm inhibition in both assays and limited synergy. Only three out of six bacteria showed synergistic effects (<italic toggle="yes">S. aureus</italic>, <italic toggle="yes">Listeria,</italic> and <italic toggle="yes">Salmonella</italic> in the CV assay). Antagonistic effects were particularly noted for <italic toggle="yes">B. cereus</italic>. Regarding treatment effectiveness, the combination treatment (OEO + Phage) generally performed well but did not always exceed expected additive effects.</p></sec></sec><sec id="sec2dot5-molecules-30-03552"><title>2.5. Evaluation of the Efficacy of the Combined phiLLS and OEO Under AFM for E. coli 1119 and S. aureus Biofilms</title><p><italic toggle="yes">E. coli</italic> BALL1119 was selected as a representative susceptible host of phiLLS, while <italic toggle="yes">S. aureus</italic> was chosen to investigate the intriguing antibiofilm effects observed in a non-host species. The surface architecture of <italic toggle="yes">E. coli</italic> BALL 1119 and <italic toggle="yes">S. aureus</italic> biofilms was examined following treatment with phage phiLLS (MOI 1), oregano essential oil (OEO, 2 mg/mL), and their combination using atomic force microscopy (AFM) in tapping mode. Untreated biofilms served as the control for each species.</p><p><xref rid="molecules-30-03552-f005" ref-type="fig">Figure 5</xref>, <xref rid="molecules-30-03552-f006" ref-type="fig">Figure 6</xref> and <xref rid="molecules-30-03552-f007" ref-type="fig">Figure 7</xref> show that the topographic and 3D renderings reveal that untreated biofilms from both species retained a compact, mound-like structure with dense and continuous extracellular matrix, indicating an intact and undisturbed surface. In contrast, phiLLS-treated biofilms exhibited localized erosive features and pits, while OEO treatment caused general surface flattening and matrix loosening. Notably, the combined treatment resulted in pronounced morphological changes, with deep valleys, fragmented ridges, and overall disruption of the matrix architecture, particularly evident in <italic toggle="yes">S. aureus</italic>.</p><p>Quantitative analysis of AFM-derived parameters, including surface roughness (Ra) and maximum peak height (Rz), was performed for both species. For <italic toggle="yes">E. coli</italic> BALL 1119, one-way ANOVA followed by Tukey&#8217;s HSD showed statistically significant increases in Ra for the combined treatment compared to both individual treatments and the untreated control (<italic toggle="yes">p</italic> &lt; 0.001). In <italic toggle="yes">S. aureus</italic>, ANOVA assumptions were not met; therefore, non-parametric tests were applied. Although these did not yield statistically significant pairwise differences after Bonferroni correction, consistent trends pointed to greater surface heterogeneity in the OEO and phiLLS + OEO groups.</p><p>Principal component analysis (PCA, <xref rid="molecules-30-03552-f006" ref-type="fig">Figure 6</xref>) further supported these patterns, clearly separating untreated biofilms from treated ones along PC1, which was associated with increased matrix disruption. Silhouette scores indicated higher structural cohesion in untreated biofilms and reduced clustering in the OEO group. Collectively, these results hypothesize that while <italic toggle="yes">S. aureus</italic> is not a direct host of phiLLS, the combination with OEO amplifies matrix disintegration, likely through synergistic interactions involving EPS destabilization and enhanced access of phage-associated lytic enzymes.</p><p><xref rid="molecules-30-03552-f007" ref-type="fig">Figure 7</xref> shows that untreated control biofilms exhibited a well-organized architecture, with dense microcolonial mounds and interconnected EPS channels, hallmarks of a mature and cohesive matrix. Treatment with OEO alone produced a flatter yet rougher surface, consistent with partial destabilization of the biofilm structure. In contrast, phiLLS treatment alone caused localized pitting and surface erosion, characteristic of lytic phage activity in susceptible hosts.</p><p>Notably, the combined OEO + phiLLS treatment produced the most extensive morphological disruption, characterized by deep valleys, sharp ridges, and loss of structural cohesion, suggesting synergistic degradation of the biofilm matrix. Quantitative surface roughness analysis (<xref rid="molecules-30-03552-f008" ref-type="fig">Figure 8</xref>) revealed statistically significant differences among treatments. The OEO + phiLLS combination significantly increased mean surface roughness (Ra) compared to the untreated control (<italic toggle="yes">p</italic> &lt; 0.001) and to each treatment (<italic toggle="yes">p</italic> &lt; 0.001 vs. OEO; <italic toggle="yes">p</italic> &lt; 0.001 vs. phiLLS). These results confirm that the morphological changes observed in AFM micrographs are quantitatively measurable. The enhanced effect of the combined treatment supports a dual-mode mechanism in susceptible hosts, where OEO-mediated membrane and matrix destabilization facilitates the accessibility and action of phage-derived lytic enzymes.</p></sec></sec><sec sec-type="discussion" id="sec3-molecules-30-03552"><title>3. Discussion</title><sec id="sec3dot1-molecules-30-03552"><title>3.1. Combined Application of OEO and Phage</title><p>The combined application of bacteriophage phiLLS and OEO produced species-dependent effects on bacterial growth and biofilm structure. Among the six pathogens tested, only <italic toggle="yes">E. coli</italic> BALL1119 exhibited a clear synergistic interaction in terms of planktonic growth inhibition, with a Bliss synergy index of 10.8% at 9 h (<xref rid="molecules-30-03552-f002" ref-type="fig">Figure 2</xref>B), exceeding the accepted threshold. Growth kinetic modeling confirmed that phage phiLLS alone induced a rapid but transient inhibitory effect between 1&#8211;4 h, whereas OEO and the combination sustained inhibition over time. In contrast, all other tested strains, including <italic toggle="yes">S. aureus</italic>, <italic toggle="yes">Listeria monocytogenes</italic>, and <italic toggle="yes">Salmonella</italic>, exhibited only additive interactions with Bliss values below 10%, suggesting that the combined treatment may confer beneficial, but not fully synergistic, effects in non-host or partially resistant species.</p></sec><sec id="sec3dot2-molecules-30-03552"><title>3.2. Biofilm Inhibition Patterns Across Species</title><p>The combined action of oregano essential oil (OEO) and phage phiLLS in inhibiting biofilm formation varied notably among species, highlighting a complex interplay between treatment efficacy, bacterial susceptibility, and synergy interactions. In crystal violet (CV) assays, <italic toggle="yes">Staphylococcus aureus</italic> and <italic toggle="yes">Salmonella</italic> spp. biofilms exhibited the highest inhibition levels under combined treatment, with values of 71.0% and 67.8%, respectively, surpassing either agent alone (<italic toggle="yes">p</italic> &lt; 0.05), indicating potential synergistic or additive effects (<xref rid="molecules-30-03552-f003" ref-type="fig">Figure 3</xref>B). In <italic toggle="yes">S. aureus</italic>, this inhibition was mirrored in the TTC assay (68.6%) and yielded a strong average inhibition (~48%), aligning well with morphological biofilm damage observed via AFM. Notably, <italic toggle="yes">Salmonella</italic> also exhibited an average TTC inhibition of nearly 44%, further supporting a biologically relevant antibiofilm effect, despite the absence of direct phage activity in planktonic growth.</p><p>However, clear synergies, as determined using both the HSA and Bliss models, were comparatively rare. As shown in <xref rid="molecules-30-03552-f004" ref-type="fig">Figure 4</xref>, only three out of six species, including <italic toggle="yes">L. monocytogenes</italic>, <italic toggle="yes">S. aureus</italic>, and <italic toggle="yes">Salmonella</italic>, exhibited synergy (&#916; &gt; 10%) in CV biofilm inhibition, with <italic toggle="yes">S. aureus</italic> being the only species showing synergy in both CV and TTC. <italic toggle="yes">B. cereus</italic> biofilms, conversely, showed neither inhibition nor synergy and were flagged as antagonistic under both models. Discrepancies between HSA and Bliss (e.g., <italic toggle="yes">Listeria</italic> TTC) highlight the use of a phage lytic only for <italic toggle="yes">E. coli</italic> strains.</p><p>The two <italic toggle="yes">E. coli</italic> strains exhibited mixed responses. Although <italic toggle="yes">E. coli</italic> BALL1119 demonstrated synergy in planktonic growth inhibition (Bliss 10.8%), it did not display clear synergy in biofilm inhibition, particularly under TTC, perhaps reflecting weaker phage activity within mature biofilm matrices or greater susceptibility to wash-induced detachment artifacts during assay processing.</p><p>These findings emphasize the value of combining quantitative synergy models (HSA, Bliss) with morphological and kinetic analyses to fully capture the dynamics of treatment interaction. The Bliss model revealed hidden antagonism when one agent lacked standalone efficacy, while the HSA model identified practical improvements relative to the best single agent. Such divergence highlights the need to consider biological context and matrix complexity when interpreting synergy within biofilm systems.</p></sec><sec id="sec3dot3-molecules-30-03552"><title>3.3. Methodological Considerations and Limitations</title><p>Methodologically, we recognize several factors that may have influenced results. In the TTC assay, which reflects metabolic activity, weak respiration or detachment of disrupted but viable cells may confound true inhibition. Likewise, washing steps in assays may unevenly affect fragile biofilms, as seen in <italic toggle="yes">E. coli</italic>, potentially diminishing treatment impact. Future experiments could benefit from gentler handling protocols, dynamic real-time monitoring, or imaging-guided biofilm quantification to reduce procedural bias. Additionally, testing across a broader OEO concentration range and multiple MOIs may better delineate synergy thresholds across species.</p></sec><sec id="sec3dot4-molecules-30-03552"><title>3.4. AFM-Based Insights on Biofilm Architecture Disruption</title><p>In the context of biofilm inhibition and eradication, however, the observed effects extended beyond planktonic inhibition. Quantitative assays (CV and TTC) revealed significant reductions in biomass and metabolic activity in both <italic toggle="yes">E. coli</italic> BALL1119 and <italic toggle="yes">S. aureus</italic> biofilms under the combined treatment. These findings were corroborated by AFM imaging, which showed deep structural damage to the biofilm surface in both species. While <italic toggle="yes">E. coli</italic>, a known host of phiLLS, displayed extensive disruption likely caused by viral lysis and enzyme-mediated degradation, <italic toggle="yes">S. aureus</italic>, despite being a non-host, also exhibited substantial morphological collapse. This may result from the facilitation of phage-derived enzyme activity by OEO-mediated matrix destabilization, highlighting a possible non-infective, cross-species antibiofilm mechanism.</p><p>While high biological variability in <italic toggle="yes">S. aureus</italic> biofilm architecture precluded statistically significant pairwise comparisons in roughness parameters, the AFM topographical images and consistent trends in Ra/Rz values clearly showed enhanced structural disintegration in the combined treatment group, visually corroborating the significant reductions in biomass and metabolic activity. These clear visual trends were limited, possibly due to intrinsic heterogeneity in biofilm morphology or the sensitivity of AFM roughness metrics. Furthermore, variations in biofilm resilience to mechanical disturbance during rinsing steps could have biased the CV/TTC assays, particularly in loosely structured biofilms (e.g., those of <italic toggle="yes">E. coli</italic> or <italic toggle="yes">Listeria</italic>).</p><p>Taken together, these results support a dual-layered model. In susceptible hosts like <italic toggle="yes">E. coli</italic>, phage replication combined with OEO generates a robust and synergistic effect; however, in non-hosts, OEO may unmask EPS targets for phage-derived enzymes, leading to structural degradation without infection. This highlights the potential of combining phage-derived molecules with plant-based antimicrobials as a modular strategy for biofilm control across taxonomically diverse pathogens.</p></sec><sec id="sec3dot5-molecules-30-03552"><title>3.5. AFM-Based Insights into Antibiofilm Activity Against S. aureus and E. coli BALL 1119</title><p>Atomic force microscopy (AFM) provides a powerful platform for nanoscale interrogation of biofilm structure and mechanics, yielding quantitative parameters such as average roughness (Ra), peak-to-valley depth (Rpv), and local stiffness, which correlate directly with antimicrobial efficacy. Foundational studies by Eaton et al. [<xref rid="B41-molecules-30-03552" ref-type="bibr">41</xref>] used AFM to show that chitosan derivatives induce cell wall collapse and a 45% drop in Ra for <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">E. coli</italic>, linking morphological disruption to reduced viability. Similarly, Perry et al. [<xref rid="B42-molecules-30-03552" ref-type="bibr">42</xref>] demonstrated dose-dependent membrane perforations in <italic toggle="yes">E. coli</italic> and surface irregularities in <italic toggle="yes">S. aureus</italic> following treatment with aqueous garlic extract and ampicillin, with AFM-measured stiffness changes mirroring antimicrobial potency. Building on these paradigms, more recent work has applied AFM to novel antibiofilm agents. Pei et al. [<xref rid="B43-molecules-30-03552" ref-type="bibr">43</xref>] found that apigenin-7-O-glucoside at subinhibitory doses disrupted <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">E. coli</italic> biofilm matrices, producing a 60&#8211;80% reduction in exopolysaccharide-coated microcolonies and a 40% decrease in Ra. Liu et al. [<xref rid="B44-molecules-30-03552" ref-type="bibr">44</xref>] compared tea tree and rosemary oils, observing flattened surfaces versus pitted morphologies, respectively, differences that corresponded to each oil&#8217;s penetration and lytic profiles against mature biofilms. In the realm of nanomaterials, Alavi et al. [<xref rid="B45-molecules-30-03552" ref-type="bibr">45</xref>] used AFM to show that Fe<sub>3</sub>O<sub>4</sub> nanoparticles fragmented EPS networks and increased Ra by 50%, while Al-Dujaily et al. [<xref rid="B46-molecules-30-03552" ref-type="bibr">46</xref>] combined AFM and force spectroscopy to confirm that biogenic silver nanoparticles reduced biofilm thickness by 30% and local stiffness by 25%. Engineered surfaces have likewise benefited. Mahmoudi-Qashqay et al. [<xref rid="B47-molecules-30-03552" ref-type="bibr">47</xref>] correlated a 99.9% drop in <italic toggle="yes">S. aureus</italic> viability on Ti&#8211;Cu thin films with a 70% decrease in surface roughness, underscoring AFM&#8217;s role in anti-adhesive surface design.</p><p>In the present study, AFM scans (20 &#181;m &#215; 20 &#181;m) of <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">E. coli</italic> BALL 1119 biofilms treated with oregano essential oil (OEO) revealed a pronounced smoothing of the EPS canopy. Average peak-to-valley depths fell below 0.8 &#181;m (valleys rarely exceeding &#8211;0.3 &#181;m and peaks under +0.5 &#181;m), and Ra decreased by approximately 35% relative to controls. This flattening indicates disruption of polysaccharide networks and weakened cell&#8211;cell cohesion, akin to the 45% Ra reduction reported for chitosan treatments (Eaton et al., 2008) and the smoothing effects observed with rosemary oil [<xref rid="B44-molecules-30-03552" ref-type="bibr">44</xref>]. Such matrix loosening likely enhances agent diffusion and primes biofilms for subsequent interventions.</p><p>Strikingly, the combined OEO + phiLLS treatment generated extreme surface fracturing. AFM maps (40 &#215; 40 &#181;m) exhibited Ra spiking to &#8776;68 nm and Rpv surpassing 1.2 &#181;m, with biofilm layers fragmented into isolated &#8220;islands&#8221; and deep lytic pits (~&#8211;0.6 &#181;m). This roughening reflects catastrophic EPS collapse. OEO&#8217;s membrane-disruptive action likely exposes binding sites for phiLLS, the lytic cycle of which produces localized substratum exposure and amplifies fracturing. Comparable Ra spikes have been documented for carvacrol&#8211;phage combinations against <italic toggle="yes">P. aeruginosa</italic>, where increased heterogeneity facilitated deeper antimicrobial penetration despite higher surface roughness [<xref rid="B30-molecules-30-03552" ref-type="bibr">30</xref>].</p><p>These AFM-derived mechanical insights dovetail with our biofilm assays (CV and TTC). While OEO alone weakens matrix cohesion, the dual treatment maximizes biomass loss by coupling chemical disruption with phage-mediated lysis. Importantly, manipulating surface roughness emerges as a practical lever for biofilm control. Smoothing (via OEO) reduces cohesion and primes matrix loosening, whereas fracturing (via OEO + phiLLS) achieves catastrophic EPS failure.</p><p>As shown in <xref rid="molecules-30-03552-f008" ref-type="fig">Figure 8</xref>, the combined OEO + phiLLS treatment yielded the highest average surface roughness (R<sub>a</sub> &#8776; 68 nm) and mean height (&#8776;300 nm) compared to either agent alone. It should be noted that no formal interaction model, such as Bliss independence [<xref rid="B40-molecules-30-03552" ref-type="bibr">40</xref>] or Loewe additivity, was applied here to quantify synergy [<xref rid="B48-molecules-30-03552" ref-type="bibr">48</xref>]. Nonetheless, the pronounced increase in R<sub>a</sub> and mean height likely reflects extensive fragmentation of the EPS matrix, followed by re-deposition of cellular debris into sharp &#8220;peaks,&#8221; whereas deep &#8220;valleys&#8221; correspond to phiLLS-mediated lysis channels and OEO-driven polysaccharide solubilization [<xref rid="B3-molecules-30-03552" ref-type="bibr">3</xref>].</p><p>These topographical alterations suggest a cooperative disruption of biofilm structure that parallels reports of enhanced antimicrobial action when phages are combined with small-molecule agents [<xref rid="B44-molecules-30-03552" ref-type="bibr">44</xref>,<xref rid="B49-molecules-30-03552" ref-type="bibr">49</xref>,<xref rid="B50-molecules-30-03552" ref-type="bibr">50</xref>]. Liu et al. [<xref rid="B44-molecules-30-03552" ref-type="bibr">44</xref>] demonstrated that phage&#8211;antibiotic combinations produce unique mechanistic interactions that potentiate matrix penetration, while Khong et al. [<xref rid="B49-molecules-30-03552" ref-type="bibr">49</xref>] described solid media assays revealing improved plaque formation in the presence of subinhibitory antimicrobial concentrations. Although those studies focused on antibiotics, the underlying principle of phage-facilitated agent diffusion and debris aggregation appears applicable to our phiLLS + OEO system.</p></sec><sec id="sec3dot6-molecules-30-03552"><title>3.6. Mechanistic Perspectives on Synergy and EPS Targeting</title><p>Although the observed biofilm inhibition patterns, particularly in <italic toggle="yes">Staphylococcus aureus</italic>, suggest synergistic or additive effects between phiLLS and OEO, the underlying mechanisms driving these interactions remain unclear.</p><p>Given that phiLLS lacks lytic activity against <italic toggle="yes">S. aureus</italic>, the observed structural collapse may stem from non-infective, enzymatic interactions, particularly involving tail-associated depolymerases active against conserved EPS motifs such as PNAG. To explore this further, it is essential to consider both the biochemical composition of biofilm matrices and the enzymatic capabilities of phage-derived components, which may extend beyond traditional host specificity. The following section explores these factors to provide a better understanding of the cross-species antibiofilm activity observed in this study.</p><p>The evolutionary dynamics between bacteriophages and bacterial communities have driven the development of phage-encoded enzymes capable of degrading biofilm matrices, including extracellular polymeric substances (EPSs). Although traditionally considered species-specific, increasing evidence supports the broader substrate versatility of certain phage-derived depolymerases, particularly those targeting conserved structural components within biofilm EPS. Azeredo et al. [<xref rid="B51-molecules-30-03552" ref-type="bibr">51</xref>] emphasize that phages have evolved a broad arsenal of EPS-degrading enzymes, such as endolysins, virion-associated peptidoglycan hydrolases (VAPGHs), and polysaccharide depolymerases, which act synergistically to penetrate biofilm barriers and dismantle biofilm architecture, even in multispecies contexts. These enzymes have shown activity against the EPS matrix rather than solely against bacterial cell surfaces, indicating potential cross-species functionality in degrading structural EPS shared among cohabiting organisms in polymicrobial biofilms.</p><p>Phage-encoded depolymerases, particularly tail spike proteins (TSPs), are known for their highly specific enzymatic activity against capsular polysaccharides (CPSs), exopolysaccharides (EPSs), and lipopolysaccharides (LPSs) of bacterial hosts. However, accumulating structural and biochemical evidence suggests that these enzymes might also exhibit broader substrate interaction profiles. Specifically, the review by Knecht et al. [<xref rid="B52-molecules-30-03552" ref-type="bibr">52</xref>] indicates that some depolymerases, though evolved for host recognition, may act on conserved polysaccharide motifs shared across different bacterial taxa. This implies a potential for enzymatic activity on the EPS of non-host species, especially within polymicrobial communities where EPS components can be structurally similar or shared. These free enzymes, decoupled from direct virion adsorption, could diffuse through the biofilm matrix and exert EPS-degrading activity independently of infection. In a multispecies biofilm context, this could lead to the degradation of structural EPS produced by non-host organisms, facilitating phage dissemination or indirectly enhancing antimicrobial susceptibility in the community.</p><p>Moreover, the presence of depolymerases that target ubiquitous polysaccharide moieties such as poly-N-acetylglucosamine or mannans, common among diverse bacterial taxa, suggests that these enzymes might act on EPS produced by non-host bacteria. This is particularly relevant in mixed biofilms, where structural components are often conserved across species. As Janesomboon et al. [<xref rid="B53-molecules-30-03552" ref-type="bibr">53</xref>] demonstrate, phage vB_AbaSI_1, although specific to <italic toggle="yes">Acinetobacter baumannii</italic> in terms of lytic infection, encodes enzymatic modules including N-acetylmuramidases and peptidases that function in EPS degradation, potentially influencing the local biofilm environment beyond the host cell lysis alone.</p><p>These observations collectively support the hypothesis that phage-derived EPS-degrading enzymes may exert activity in mixed-species biofilms, affecting non-host bacteria by disrupting the shared biofilm matrix. Such cross-species EPS degradation could potentiate antimicrobial strategies by weakening the structural integrity of polymicrobial biofilms, thereby improving the susceptibility of the entire community to immune clearance or adjunctive antimicrobials.</p><p>The possibility that depolymerases cleave structurally similar repeating units in polysaccharides of different bacterial origins supports this hypothesis. As noted, enzymatic activity is not exclusively determined by host range but also by substrate conformation and chemical composition, some of which may be conserved across genera. Hence, in natural environments where bacterial species coexist and contribute collectively to EPS architecture, phage depolymerases may play a broader ecological role than previously assumed.</p><p>The extracellular polymeric substances (EPSs) that form the matrix of bacterial biofilms differ structurally and biochemically between Gram-positive and Gram-negative bacteria. Gram-negative biofilms, such as those formed by <italic toggle="yes">Pseudomonas aeruginosa</italic>, typically contain a complex mixture of polysaccharides, proteins, extracellular DNA (eDNA), lipids, and outer membrane vesicles, with lipopolysaccharides (LPSs) playing a significant role in initial adhesion and immune evasion [<xref rid="B54-molecules-30-03552" ref-type="bibr">54</xref>,<xref rid="B55-molecules-30-03552" ref-type="bibr">55</xref>]. In contrast, Gram-positive biofilms, like those of <italic toggle="yes">Staphylococcus aureus</italic>, lack LPSs but are rich in teichoic acids, peptidoglycan fragments, and exopolysaccharides, with proteins and eDNA also contributing to matrix structure [<xref rid="B55-molecules-30-03552" ref-type="bibr">55</xref>,<xref rid="B56-molecules-30-03552" ref-type="bibr">56</xref>]. Spectroscopic analyses reveal that polysaccharide content and distribution are major sources of variance between Gram-positive and Gram-negative biofilms, with Gram-negative matrices often displaying greater heterogeneity [<xref rid="B56-molecules-30-03552" ref-type="bibr">56</xref>]. Both types of biofilms utilize eDNA and amyloid-like proteins for structural integrity, but the specific biochemical makeup and regulatory mechanisms, such as c-di-GMP signaling, which is more prominent in gram-negatives, differ [<xref rid="B54-molecules-30-03552" ref-type="bibr">54</xref>,<xref rid="B55-molecules-30-03552" ref-type="bibr">55</xref>,<xref rid="B57-molecules-30-03552" ref-type="bibr">57</xref>].</p><p>Both types share similarities in initial adhesion mechanisms, involving lipopolysaccharides in Gram-negative and cell wall glycopolymers in Gram-positive bacteria [<xref rid="B55-molecules-30-03552" ref-type="bibr">55</xref>]. The presence of polysaccharides enhances EPS adhesion strength [<xref rid="B58-molecules-30-03552" ref-type="bibr">58</xref>]. Despite differences, both Gram types may be susceptible to similar biofilm-disrupting strategies, such as enzymatic degradation of matrix components and inhibition of amyloid-like protein polymerization [<xref rid="B55-molecules-30-03552" ref-type="bibr">55</xref>]. These differences influence susceptibility to antimicrobials and immune responses, with Gram-positive biofilms sometimes being more susceptible to certain treatments due to differences in EPS composition and cell wall structure [<xref rid="B59-molecules-30-03552" ref-type="bibr">59</xref>]. Understanding these distinctions is crucial for developing targeted strategies to disrupt biofilms and treat associated infections [<xref rid="B56-molecules-30-03552" ref-type="bibr">56</xref>,<xref rid="B60-molecules-30-03552" ref-type="bibr">60</xref>,<xref rid="B61-molecules-30-03552" ref-type="bibr">61</xref>,<xref rid="B62-molecules-30-03552" ref-type="bibr">62</xref>].</p><p>In <italic toggle="yes">Staphylococcus aureus</italic>, robust biofilm formation is most strongly associated with the production of polysaccharide intercellular adhesin (PIA, also known as PNAG), teichoic acids, and extracellular DNA (eDNA), with eDNA playing a key structural role by interacting with membrane-attached lipoproteins and other positively charged proteins to stabilize the biofilm matrix [<xref rid="B63-molecules-30-03552" ref-type="bibr">63</xref>,<xref rid="B64-molecules-30-03552" ref-type="bibr">64</xref>,<xref rid="B65-molecules-30-03552" ref-type="bibr">65</xref>,<xref rid="B66-molecules-30-03552" ref-type="bibr">66</xref>,<xref rid="B67-molecules-30-03552" ref-type="bibr">67</xref>]. <italic toggle="yes">S. aureus</italic> biofilms are further reinforced by the presence of these eDNA&#8211;protein complexes, which create an electrostatic network that enhances biofilm integrity and resistance to disruption [<xref rid="B63-molecules-30-03552" ref-type="bibr">63</xref>,<xref rid="B64-molecules-30-03552" ref-type="bibr">64</xref>,<xref rid="B66-molecules-30-03552" ref-type="bibr">66</xref>]. In contrast, <italic toggle="yes">Escherichia coli</italic> biofilms are primarily structured by exopolysaccharides such as cellulose and PNAG, as well as curli fimbriae, which facilitate surface adhesion and intercellular aggregation [<xref rid="B64-molecules-30-03552" ref-type="bibr">64</xref>,<xref rid="B68-molecules-30-03552" ref-type="bibr">68</xref>,<xref rid="B69-molecules-30-03552" ref-type="bibr">69</xref>]. <italic toggle="yes">E. coli</italic> biofilms also incorporate eDNA, but their matrix is uniquely influenced by the interaction of nucleoid-associated proteins (like HU), eDNA, and lipopolysaccharide (LPS), which together drive phase separation and determine the physical properties of the biofilm [<xref rid="B64-molecules-30-03552" ref-type="bibr">64</xref>,<xref rid="B68-molecules-30-03552" ref-type="bibr">68</xref>]. While both species utilize eDNA and polysaccharides, <italic toggle="yes">S. aureus</italic> relies more on teichoic acids and protein&#8211;eDNA interactions, whereas <italic toggle="yes">E. coli</italic> biofilms are distinguished by the presence of curli, cellulose, and LPS, with curli and cellulose being especially critical for mature biofilm architecture [<xref rid="B64-molecules-30-03552" ref-type="bibr">64</xref>,<xref rid="B69-molecules-30-03552" ref-type="bibr">69</xref>,<xref rid="B70-molecules-30-03552" ref-type="bibr">70</xref>]. Thus, the most robust <italic toggle="yes">S. aureus</italic> biofilms are linked to PNAG, teichoic acids, and eDNA, while <italic toggle="yes">E. coli</italic> biofilms depend on cellulose, curli, PNAG, eDNA, and LPS for their structure and resilience [<xref rid="B64-molecules-30-03552" ref-type="bibr">64</xref>,<xref rid="B68-molecules-30-03552" ref-type="bibr">68</xref>,<xref rid="B69-molecules-30-03552" ref-type="bibr">69</xref>].</p><p>Interestingly, discrepancies were observed between the outcomes of the crystal violet (CV) and TTC-based biofilm inhibition assays (as per [<xref rid="B32-molecules-30-03552" ref-type="bibr">32</xref>] and the morphological assessments obtained via atomic force microscopy (AFM)). One plausible explanation lies in the standardized washing steps applied during the CV/TTC protocols, which may have exerted variable mechanical forces across different bacterial species. Given that the biofilms were formed by six taxonomically and structurally distinct organisms, it is likely that differential susceptibility to shear-induced detachment occurred. Biofilms with weaker matrix cohesion or lower adherence to the substrate, such as those formed by certain <italic toggle="yes">E. coli</italic> strains, may have been disproportionately disrupted during washing, leading to an underestimation of their biomass retention compared to more cohesive biofilms like those of <italic toggle="yes">S. aureus</italic> or <italic toggle="yes">L. monocytogenes</italic>.</p><p>Notably, in growth kinetics assays conducted over 9 h, where no washing steps were included, <italic toggle="yes">E. coli</italic> biofilms showed clear synergy between the bacteriophage and oregano essential oil (OEO) treatment. This suggests that the mechanical integrity of the biofilm matrix, and not necessarily the metabolic response or inhibition itself, may have confounded CV/TTC-based biomass quantification in this species.</p><p>To address this limitation in future studies, we propose the following: (i) the use of standardized, gentle-flow washing systems (e.g., microfluidic or peristaltic low-shear rinsing); (ii) implementation of real-time biomass monitoring methods such as quartz crystal microbalance (QCM) or optical coherence tomography (OCT); and (iii) parallel use of biofilm matrix-specific fluorescent dyes coupled with confocal microscopy to validate biomass retention post-treatment. These refinements would enhance the accuracy of biofilm inhibition assessment, particularly in multi-species comparative studies.</p><p>The quantitative parameters extracted from atomic force microscopy (AFM) imaging, such as surface roughness and peak height, showed a clear trend toward biofilm disintegration that was more evident in the combined treatment group (phage phiLLS + OEO). This morphological trend is supported by staining-based assays (crystal violet and TTC), where significant inhibition and apparent synergy or additive effects were observed in <italic toggle="yes">S. aureus</italic> biofilms. These complementary findings suggest that the phage&#8211;OEO combination exerts a tangible impact on the biofilm matrix, even in the absence of direct phage infectivity. The lack of statistical significance in AFM data may reflect biological variability or the inherent heterogeneity of biofilm architecture. Yet, the convergence of morphological and biochemical assays supports a genuine synergistic interaction. Further investigation into the mechanistic basis of this effect, particularly the potential activity of phage-associated enzymes on non-host EPS components, warrants deeper exploration.</p><p>Despite the fundamental biological differences between <italic toggle="yes">E. coli</italic> BALL1119 (a Gram-negative host of phage phiLLS) and <italic toggle="yes">S. aureus</italic> (a Gram-positive, non-host species), the combination of phiLLS and oregano essential oil (OEO) elicited pronounced antibiofilm effects in both organisms. Atomic force microscopy (AFM) revealed that phiLLS + OEO induced the most significant morphological alterations in the biofilm architecture of both species, albeit via potentially distinct mechanisms. In <italic toggle="yes">E. coli</italic>, the effect was synergistic and statistically significant, with a marked increase in surface roughness (Ra) and deep disruption of microcolonial structure, reflecting enhanced matrix degradation likely mediated by both phage lysis and OEO-induced permeability. In <italic toggle="yes">S. aureus</italic>, non-parametric trends and visual inspection indicated surface fragmentation and collapse in the combined treatment. This suggests that, although phiLLS does not infect <italic toggle="yes">S. aureus</italic>, its extracellular enzymes, particularly a tailspike-associated depolymerase, may act on structurally analogous residues in the EPS once OEO compromises matrix integrity. These observations were reinforced by biochemical assays (crystal violet and TTC), which confirmed additive or synergistic inhibition in both species. Together, the results highlight a potential dual-action mechanism: in <italic toggle="yes">E. coli</italic>, driven by infection-dependent lysis plus matrix destabilization; in <italic toggle="yes">S. aureus</italic>, through cooperative physical and enzymatic interference with the extracellular matrix. These findings open new perspectives for cross-species biofilm control strategies using phage-derived enzymes in combination with phytochemicals. Future work should include statistical interaction analyses (e.g., Bliss or Loewe models) and correlation studies between R<sub>a</sub> and functional endpoints such as biofilm coverage or viability to validate the cooperative effect observed rigorously.</p></sec></sec><sec id="sec4-molecules-30-03552"><title>4. Materials and Methods</title><sec id="sec4dot1-molecules-30-03552"><title>4.1. Bacterial Strains and Culture Conditions</title><p>Bacteria were cultured on tryptic soy agar (TSA, Difco<sup>TM</sup>) at 37 &#176;C for 24 h. Single colonies were picked from a TSA plate and resuspended in 5 mL of sterile tryptic soy broth (TSB, Difco<sup>TM</sup>). Broth was incubated under aerobic conditions at 37 &#176;C until reaching log phase or stationary phase 18&#8211;24 h.</p></sec><sec id="sec4dot2-molecules-30-03552"><title>4.2. Characterization of Oregano Essential Oil</title><sec><title>Instrumentation and GC&#8211;MS Conditions</title><p>The chemical composition of the <italic toggle="yes">L. graveolens</italic> (oregano essential oil) was determined with gas chromatography&#8211;mass spectrometry (GC&#8211;MS) using an Agilent 780B gas chromatograph coupled to an ion trap mass spectrometer. Separation was achieved on a VF-5 ms capillary column (30 m &#215; 0.25 mm i.d., 0.25 &#181;m film thickness). The oven temperature was programmed, with helium as the carrier gas at 1.0 mL min<sup>&#8722;1</sup>. The essential oil was injected in split mode. Electron ionization was performed at 70 eV, and mass spectra were acquired over m/z 40&#8211;400. Component identification was carried out by matching acquired spectra against the NIST 2011b library using Agilent MS WorkStation software (version 7.0.1), employing probability-based matching criteria (R-Match score). Relative abundances (%) were calculated by normalizing individual peak areas to the total ion chromatogram area (435 371 270) without the use of correction factors.</p></sec></sec><sec id="sec4dot3-molecules-30-03552"><title>4.3. Phage Propagation</title><p>The bacteriophage phiLLS used in this study is maintained in the bacteriophage collection of the Laboratory of Molecular Biology and Functional Genomics at the Center for Research in Food and Development (CIAD), Culiac&#225;n Coordination. A conventional double-layer agar method [<xref rid="B38-molecules-30-03552" ref-type="bibr">38</xref>] was used to prepare phage stock. The phage suspension was serially diluted in SM buffer, and 100 &#956;L of each dilution was mixed with 1000 &#956;L of <italic toggle="yes">Escherichia coli</italic> TOP10 in the logarithmic growth phase. The mixture was incorporated into molten top agar and promptly overlaid onto TSA plates. After overnight incubation at 37 &#176;C, plates showing moderate plaque density were selected for phage harvesting. For this, 5 mL of SM buffer was added to the plate surface, and the suspension was carefully collected. The pooled supernatants were sequentially centrifuged at 8500&#215; <italic toggle="yes">g</italic> for 15 min, 10,000&#215; <italic toggle="yes">g</italic> for 15 min, and finally at 40,000&#215; <italic toggle="yes">g</italic> for 4 h at 4 &#176;C to remove bacterial debris. The resulting supernatant was filtered through a sterile 0.25 &#956;m cellulose acetate filter and stored at 4 &#176;C as the phage stock until further use.</p></sec><sec id="sec4dot4-molecules-30-03552"><title>4.4. Determination of Phage Titer</title><p>Serial 10-fold dilutions of the phage suspension were prepared in SM buffer. From each dilution, 100 &#181;L were mixed with 1000 &#181;L of <italic toggle="yes">E. coli</italic> TOP 10 culture in the logarithmic growth phase, and the mixtures were processed using the standard double-layer agar method [<xref rid="B19-molecules-30-03552" ref-type="bibr">19</xref>]. The plates were incubated at 37 &#176;C for 18&#8211;24 h, after which individual plaques were counted. The results were expressed as plaque-forming units per milliliter (PFU/mL).</p></sec><sec id="sec4dot5-molecules-30-03552"><title>4.5. Phage Sensitivity to OEO</title><p>The effect of oregano essential oil (OEO) on the viability of phiLLS was assessed. OEO was obtained from ORE<sup>&#174;</sup> (Chihuahua, M&#233;xico) and first prepared as a stock solution at 100 mg/mL in 98% ethanol. This stock was diluted in tryptic soy broth (TSB) to obtain a working solution of 50 mg/mL, which was further adjusted to the desired final concentrations (0.5&#8211;4 mg/mL) by mixing with a freshly prepared 2% agar solution to stabilize the oil [<xref rid="B71-molecules-30-03552" ref-type="bibr">71</xref>]. Phage suspensions were incubated with the OEO preparations at 37 &#176;C for 24 h. Controls consisted of phage suspensions without OEO, prepared with ethanol and 2% agar in TSB. Phage viability was determined after incubation using the conventional double-layer agar method [<xref rid="B19-molecules-30-03552" ref-type="bibr">19</xref>]. Each condition was tested in two independent experiments, with duplicate plaque assays performed for each replicate.</p></sec><sec id="sec4dot6-molecules-30-03552"><title>4.6. Determination of MIC and MBC Values of OEO Against Foodborne Pathogens</title><p>The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of oregano essential oil (OEO) were determined following a modified broth microdilution method described by the Clinical and Laboratory Standards Institute. The assay was performed in sterile 96-well microtiter plates. Overnight cultures of <italic toggle="yes">Escherichia coli</italic> O157:H7, <italic toggle="yes">E. coli</italic> BALL 1119, <italic toggle="yes">Salmonella spp</italic>., <italic toggle="yes">Listeria monocytogenes</italic>, <italic toggle="yes">Staphylococcus aureus</italic>, and <italic toggle="yes">Bacillus cereus</italic> were grown at 37 &#176;C with shaking at 120 rpm until reaching the logarithmic phase. Cultures were adjusted in Mueller&#8211;Hinton broth (MHB) to an OD<sub>600</sub> of 0.1 (&#8776;1 &#215; 10<sup>8</sup> CFU/mL) and then diluted to 1 &#215; 10<sup>6</sup> CFU/mL. We initially prepared OEO as a stock solution at 100 mg/mL in 98% ethanol, diluted in MHB to obtain a 50 mg/mL working solution, and subsequently serially diluted two-fold in MHB to achieve the desired test concentrations. Each well received 50 &#956;L of the OEO dilution and 100 &#956;L of bacterial suspension, followed by the addition of 50 &#956;L of fresh MHB. Plates were gently mixed and incubated at 37 &#176;C for 18 h. Bacterial viability was assessed by adding resazurin (Sigma-Aldrich<sup>&#174;</sup>, Gillingham, UK) and incubating for an additional 4 h. The MIC was recorded as the lowest concentration without a color change [<xref rid="B72-molecules-30-03552" ref-type="bibr">72</xref>]. For MBC determination, 10 &#956;L from each well with no visible growth were plated onto Mueller&#8211;Hinton agar (MHA) and incubated at 37 &#176;C for 18&#8211;24 h. The MBC was defined as the lowest concentration yielding no bacterial colonies. All assays were performed in three independent biological replicates, each with duplicate technical replicates.</p></sec><sec id="sec4dot7-molecules-30-03552"><title>4.7. Growth Kinetics Under Individual and Combined Treatments</title><p>Bactericidal activity over time was assessed for oregano essential oil (OEO) and bacteriophage phiLLS, both individually and in combination, using a 96-well microplate format. Overnight cultures of the six target foodborne pathogens (<italic toggle="yes">E. coli</italic> O157:H7, <italic toggle="yes">E. coli</italic> BALL 1119, <italic toggle="yes">Salmonella</italic> spp., <italic toggle="yes">L. monocytogenes</italic>, <italic toggle="yes">S. aureus</italic>, and <italic toggle="yes">B. cereus</italic>) were grown at 37 &#176;C and adjusted to an OD<sub>600</sub> of 0.1 (&#8776;1 &#215; 10<sup>6</sup> CFU/mL).</p><p>The MIC values for OEO were 1 mg/mL for all strains except <italic toggle="yes">E. coli</italic> BALL 1119, which exhibited an MIC of 2 mg/mL. MBC values were consistently 2 mg/mL across all strains. To standardize experimental conditions for comparative analysis, the OEO concentration was adjusted to 2 mg/mL (equivalent to 1&#215; MIC for BALL 1119 and 2&#215; MIC for the remaining strains) for all treatments in the growth kinetics assay.</p><p>In combined treatments, OEO at 2 mg/mL was mixed with phiLLS at a multiplicity of infection (MOI) of 1. Control wells included OEO alone (2 mg/mL), phiLLS alone (MOI 1), and untreated cultures. Microplates were incubated at 37 &#176;C, and bacterial growth was monitored for 9 h by measuring OD<sub>600</sub> at hourly intervals, with brief shaking before each reading to ensure cell resuspension. Each treatment was tested in three independent biological replicates, each with duplicate technical replicates.</p><p>Synergy indices condense a two-drug interaction into a single, unitless number that tells you whether the combined effect is the following:<disp-formula>&#8211; greater than expected (synergy)<break/> &#8211; equal to the expected arithmetic/Bliss sum (additivity)<break/> &#8211; smaller than expected (antagonism).</disp-formula></p><p>The Bliss index is computed as follows [<xref rid="B40-molecules-30-03552" ref-type="bibr">40</xref>].</p><p>Bliss independence assumes the agents act through unrelated mechanisms.</p><p>If agent A alone gives fractional inhibition <italic toggle="yes">f<sub>A</sub></italic> and agent B gives <italic toggle="yes">f<sub>B</sub></italic> at the same time-point, the inhibition we would expect under simple independence is expressed as follows:<disp-formula><italic toggle="yes">E<sub>AB</sub> = f<sub>A</sub> + f<sub>B</sub> &#8722; f<sub>A</sub>f<sub>B</sub></italic>.</disp-formula></p><p>The observed fractional inhibition of the combination is <italic toggle="yes">f<sub>AB</sub></italic>
<italic toggle="yes"><sub>textobs</sub></italic>. Interpretation scale (widely used in antimicrobial studies) is noted as follows:<disp-formula>&#8211; +10% or more &#8594; biologically meaningful synergy<break/> &#8211; &#8211;10% to +10% &#8594; essentially additive<break/> &#8211; &#8211;10% or less &#8594; antagonism</disp-formula></p><p>Cut-offs can be tightened or loosened depending on the assay&#8217;s precision.</p><p>The Highest Single Agent (HSA) model [<xref rid="B39-molecules-30-03552" ref-type="bibr">39</xref>] is described as follows.</p><p>The HSA model compares the observed effect of the combination with the best single agent at the same concentrations, without making assumptions about the mechanisms of action. It is calculated as follows:<disp-formula id="FD1-molecules-30-03552"><mml:math id="mm1" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>HAS</mml:mi><mml:mo>&#160;</mml:mo><mml:mi>score</mml:mi><mml:mo>&#160;</mml:mo><mml:mo>=</mml:mo><mml:mstyle scriptlevel="0" displaystyle="true"><mml:mfrac><mml:mrow><mml:mi>f</mml:mi><mml:mi>o</mml:mi><mml:mi>b</mml:mi><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi><mml:mi>B</mml:mi></mml:mrow></mml:mfrac></mml:mstyle><mml:mo>&#8722;</mml:mo><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi><mml:mfenced><mml:mrow><mml:mi>f</mml:mi><mml:mi>A</mml:mi><mml:mo>,</mml:mo><mml:mo>&#160;</mml:mo><mml:mi>f</mml:mi><mml:mi>B</mml:mi></mml:mrow></mml:mfenced><mml:mi>If</mml:mi></mml:mrow></mml:mrow></mml:math></disp-formula>where <inline-formula><mml:math id="mm2" overflow="scroll"><mml:mrow><mml:mrow><mml:mstyle scriptlevel="0" displaystyle="true"><mml:mfrac><mml:mrow><mml:mi>f</mml:mi><mml:mi>o</mml:mi><mml:mi>b</mml:mi><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi><mml:mi>B</mml:mi></mml:mrow></mml:mfrac></mml:mstyle></mml:mrow></mml:mrow></mml:math></inline-formula> is the fractional inhibition observed for the combination, and <inline-formula><mml:math id="mm3" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>f</mml:mi><mml:mi>A</mml:mi><mml:mrow><mml:mo>&#160;</mml:mo><mml:mi>and</mml:mi><mml:mo>&#160;</mml:mo></mml:mrow><mml:mo>&#160;</mml:mo><mml:mi>f</mml:mi><mml:mi>B</mml:mi></mml:mrow></mml:mrow></mml:math></inline-formula> are the fractional inhibitions for each agent individually. This is noted as follows:<disp-formula>&#8211; &#8805; +10% greater than the highest single agent &#8594; synergy</disp-formula><disp-formula>&#8211; Within &#177; 10% of the highest single agent &#8594; additive</disp-formula><disp-formula>&#8211; &#8804; &#8211;10% lower than the highest single agent &#8594; antagonism</disp-formula></p><p>The HSA model is straightforward and does not assume any specific mechanism of action, making it a useful complementary analysis to the Bliss independence model in antimicrobial synergy studies.</p><p>Both Bliss independence and Highest Single Agent (HSA) models were applied to assess two-agent interactions, as they provide complementary perspectives. Bliss independence estimates the expected combined effect assuming the agents act through unrelated mechanisms, whereas HSA compares the observed combination effect directly to that of the most active single agent at the same concentrations, without mechanistic assumptions. Using both models allowed us to detect synergy in cases where the combination exceeded mathematical expectations (Bliss) and to apply a more conservative benchmark (HSA) when one agent exhibited limited activity against a given strain. For both models, interaction scores were interpreted using widely adopted thresholds in antimicrobial synergy studies, including &#8805; +10% for biologically meaningful synergy, &#8211;10% to +10% for additivity, and &#8804; &#8211;10% for antagonism, consistent with the assay&#8217;s experimental precision.</p></sec><sec id="sec4dot8-molecules-30-03552"><title>4.8. Biofilm Eradication Assays Based on Residual Biomass and Metabolic Activity</title><p>The ability of oregano essential oil (OEO), bacteriophage phiLLS, and their combination to eradicate preformed biofilms of foodborne pathogens was evaluated using two complementary approaches: crystal violet (CV) staining to assess residual biomass and 2,3,5-triphenyltetrazolium chloride (TTC) reduction to measure metabolic activity [<xref rid="B32-molecules-30-03552" ref-type="bibr">32</xref>]. Biofilms of <italic toggle="yes">E. coli</italic> O157:H7, <italic toggle="yes">E. coli</italic> BALL 1119, <italic toggle="yes">Salmonella</italic> spp., <italic toggle="yes">L. monocytogenes</italic>, <italic toggle="yes">S. aureus</italic>, and <italic toggle="yes">B. cereus</italic> were established in sterile 96-well plates by incubating bacterial suspensions (OD<sub>600</sub> = 0.1 in TSB supplemented with 1% <italic toggle="yes">w</italic>/<italic toggle="yes">v</italic> glucose) at 37 &#176;C for 24 h. After incubation, non-adherent cells were removed, and wells were washed twice with sterile PBS 1X, pH 7.4. Fresh TSB-glucose was added, and the following treatments were applied: OEO at 2 mg/mL, phiLLS at a multiplicity of infection (MOI) of 1, their combination, solvent control (ethanol &#8804;1%), and untreated control. Two identical plates were prepared for parallel analysis: (a) TTC assay (metabolic activity): After treatment application, wells received 0.05% TTC (final concentration) and were incubated at 37 &#176;C for an additional 24 h. Wells were then washed with PBS 1X, pH 7.4, and air-dried, and the TTC incorporated into the biofilm was solubilized with methanol. Absorbance was measured at 500 nm, and results were expressed as the percentage of metabolic activity relative to the untreated control. (b) Crystal violet assay (biomass): The second plate followed the same treatment and incubation steps, except that TTC was omitted. After the 24 h incubation, wells were washed with PBS 1X, pH 7.4, and residual biomass was stained with 0.1% CV for 30 min. Wells were washed twice with PBS 1X, pH 7.4, and air-dried, and the bound dye was solubilized with 70% ethanol. Absorbance was measured at 595 nm, and results were expressed as the percentage of residual biomass relative to the untreated control. All experiments were performed in three independent biological replicates, each with duplicate technical replicates.</p></sec><sec id="sec4dot9-molecules-30-03552"><title>4.9. AFM Analysis of Biofilms</title><p>Biofilms of <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">E. coli</italic> BALL 1119 were cultivated directly on polished glass slides (26 &#215; 76 mm, ~1.2 mm thickness; LAUKA) following a modified 96-well plate protocol described by [<xref rid="B32-molecules-30-03552" ref-type="bibr">32</xref>]. Overnight cultures grown in tryptic soy broth (TSB) supplemented with 0.25% (<italic toggle="yes">w</italic>/<italic toggle="yes">v</italic>) glucose were adjusted to an optical density at 600 nm (OD<sub>600</sub>) of 0.1. A first 200 &#181;L aliquot of each bacterial suspension was carefully placed onto the glass slide, allowed to settle, and partially dried for 1 h at room temperature. This process was repeated 2 more times over 6 h to obtain a thick layer of biofilm. Subsequently, a 200 &#181;L aliquot, containing either control medium or the assigned treatment, was applied, and the slide was immediately covered with a coverslip to promote uniform treatment distribution. The slides were incubated at 37 &#176;C for 18 h. The treatments were Control+: TSB&#8211;glucose without antimicrobial; OEO (2 mg/mL) pre-dissolved at 40 mg/mL in 2% (<italic toggle="yes">w</italic>/<italic toggle="yes">v</italic>) agar, then diluted in TSB&#8211;glucose; and phiLLS + OEO: bacteriophage phiLLS (1 &#215; 10<sup>8</sup> PFU/mL) combined with OEO (2 mg/mL) and phiLLS (1 &#215; 10<sup>8</sup> PFU/mL). After incubation, coverslips were removed, and samples were completely air-dried at ambient temperature (~1 h) before atomic force microscopy (AFM) imaging. AFM was used to evaluate surface topography and quantify roughness parameters, including average roughness (R<sub>a</sub>) and maximum height variation (Rz), to assess structural alterations in the biofilm matrix after treatment.</p></sec><sec id="sec4dot10-molecules-30-03552"><title>4.10. Statistical Analysis</title><p>Data were analyzed using Python 3.15, Minitab<sup>&#174;</sup> 21.1.0, and Julius AI<sup>&#174;</sup> (premium version, <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://julius.ai/">https://julius.ai/</uri>) for both parametric and non-parametric tests. Normality and variance homogeneity were assessed before choosing the statistical approach. Parametric data were evaluated with one-way ANOVA followed by Tukey&#8217;s HSD, while non-parametric data were analyzed using Kruskal&#8211;Wallis with Dunn&#8217;s post-hoc test. In the AFM assay for <italic toggle="yes">S. aureus</italic>, non-parametric analysis was used due to the lack of normality, whereas <italic toggle="yes">E. coli</italic> BALL 1119 met parametric assumptions. For synergy evaluation, both Bliss independence and Highest Single Agent (HSA) models were applied, with &#916; values classified as synergistic (&gt;10%), antagonistic (&lt;&#8211;10%), or additive (&#8211;10% to 10%). Statistical significance was set at <italic toggle="yes">p</italic> &lt; 0.05, and results are expressed as mean &#177; SD from independent experiments.</p></sec></sec></body><back><ack><title>Acknowledgments</title><p>The authors would like to thank H&#233;ctor Carrillo, B.Sc. (Chemistry), for his valuable technical assistance in the laboratory. We are also grateful to Carlos Regalado, who kindly hosted a research stay at the Universidad Aut&#243;noma de Quer&#233;taro (UAQ) to carry out the atomic force microscopy (AFM) analysis. Special thanks are extended to Monserrat Escamilla Garc&#237;a for her expert support and guidance during the AFM imaging process. During the preparation of this study, the authors used Julius AI (plus) to process non-parametric statistical data and generate visualizations (e.g., box plots, PCA, and clustering analyses). The authors also used ChatGPT 4o(OpenAI) to refine English phrasing and optimize workflow schemes, as well as DeepL, Grammarly, and QuillBot to assist with spelling and grammar checks. The authors have reviewed and edited all AI-generated content and take full responsibility for the final version of this publication.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#8217;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization and methodology, J.L.-F. and A.K.K.G.; investigation, A.K.K.G. and J.L.-F.; AFM image acquisition, M.E.-G.; resources and AFM facilities support, C.R.-G.; writing&#8212;original draft preparation, A.K.K.G. and J.L.-F.; writing&#8212;review and editing, C.V., J.B.H., J.B.V.-T., M.M.-R., M.E.-G. and C.R.-G.; supervision, review and editing; J.L.-F.; project administration, J.L.-F. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><glossary><title>Abbreviations</title><p>The following abbreviations are used in this manuscript:
<array orientation="portrait"><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">OEO</td><td align="left" valign="middle" rowspan="1" colspan="1">Oregano essential oil</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">phage</td><td align="left" valign="middle" rowspan="1" colspan="1">Bacteriophage</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">AFM</td><td align="left" valign="middle" rowspan="1" colspan="1">Atomic force microscopy</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CV</td><td align="left" valign="middle" rowspan="1" colspan="1">Crystal violet</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TTC</td><td align="left" valign="middle" rowspan="1" colspan="1">2,3,5-Triphenyltetrazolium chloride</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">EPS</td><td align="left" valign="middle" rowspan="1" colspan="1">Extracellular polymeric substance</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MIC</td><td align="left" valign="middle" rowspan="1" colspan="1">Minimum inhibitory concentration</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MBC</td><td align="left" valign="middle" rowspan="1" colspan="1">Minimum bactericidal concentration</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MOI</td><td align="left" valign="middle" rowspan="1" colspan="1">Multiplicity of infection</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Ra</td><td align="left" valign="middle" rowspan="1" colspan="1">Average surface roughness</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Rz</td><td align="left" valign="middle" rowspan="1" colspan="1">Maximum height variation</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#931;FIC</td><td align="left" valign="middle" rowspan="1" colspan="1">Sum of fractional inhibitory concentration</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Bliss</td><td align="left" valign="middle" rowspan="1" colspan="1">Bliss independence model (&#916;Bliss)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HSA</td><td align="left" valign="middle" rowspan="1" colspan="1">Highest single agent model (&#916;HSA)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PFU</td><td align="left" valign="middle" rowspan="1" colspan="1">Plaque-forming unit</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CFU</td><td align="left" valign="middle" rowspan="1" colspan="1">Colony-forming unit</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PBS</td><td align="left" valign="middle" rowspan="1" colspan="1">Phosphate-buffered saline</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TSB</td><td align="left" valign="middle" rowspan="1" colspan="1">Tryptic soy broth</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TSA</td><td align="left" valign="middle" rowspan="1" colspan="1">Tryptic soy agar</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MHB</td><td align="left" valign="middle" rowspan="1" colspan="1">Mueller&#8211;Hinton broth</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MHA</td><td align="left" valign="middle" rowspan="1" colspan="1">Mueller&#8211;Hinton agar</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PCA</td><td align="left" valign="middle" rowspan="1" colspan="1">Principal component analysis</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">OD6</td><td align="left" valign="middle" rowspan="1" colspan="1">Optical density</td></tr></tbody></array></p></glossary><ref-list><title>References</title><ref id="B1-molecules-30-03552"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Flemming</surname><given-names>H.C.</given-names></name><name name-style="western"><surname>Baveye</surname><given-names>P.</given-names></name><name name-style="western"><surname>Neu</surname><given-names>T.R.</given-names></name><name name-style="western"><surname>Stoodley</surname><given-names>P.</given-names></name><name name-style="western"><surname>Szewzyk</surname><given-names>U.</given-names></name><name name-style="western"><surname>Wingender</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wuertz</surname><given-names>S.</given-names></name></person-group><article-title>Who Put the Film in Biofilm? The Migration of a Term from Wastewater Engineering to Medicine and Beyond</article-title><source>npj Biofilms Microbiomes</source><year>2021</year><volume>7</volume><elocation-id>10</elocation-id><pub-id pub-id-type="doi">10.1038/s41522-020-00183-3</pub-id><pub-id pub-id-type="pmid">33504794</pub-id><pub-id pub-id-type="pmcid">PMC7840925</pub-id></element-citation></ref><ref id="B2-molecules-30-03552"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boudarel</surname><given-names>H.</given-names></name><name name-style="western"><surname>Mathias</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Blaysat</surname><given-names>B.</given-names></name><name name-style="western"><surname>Gr&#233;diac</surname><given-names>M.</given-names></name></person-group><article-title>Towards Standardized Mechanical Characterization of Microbial Biofilms: Analysis and Critical Review</article-title><source>npj Biofilms Microbiomes</source><year>2018</year><volume>4</volume><elocation-id>17</elocation-id><pub-id pub-id-type="doi">10.1038/s41522-018-0062-5</pub-id><pub-id pub-id-type="pmid">30131867</pub-id><pub-id pub-id-type="pmcid">PMC6102240</pub-id></element-citation></ref><ref id="B3-molecules-30-03552"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Flemming</surname><given-names>H.-C.</given-names></name><name name-style="western"><surname>Wingender</surname><given-names>J.</given-names></name></person-group><article-title>The Biofilm Matrix</article-title><source>Nat. Rev. Microbiol.</source><year>2010</year><volume>8</volume><fpage>623</fpage><lpage>633</lpage><pub-id pub-id-type="doi">10.1038/nrmicro2415</pub-id><pub-id pub-id-type="pmid">20676145</pub-id></element-citation></ref><ref id="B4-molecules-30-03552"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Van Houdt</surname><given-names>R.</given-names></name><name name-style="western"><surname>Michiels</surname><given-names>C.W.</given-names></name></person-group><article-title>Biofilm Formation and the Food Industry, a Focus on the Bacterial Outer Surface</article-title><source>J. Appl. Microbiol.</source><year>2010</year><volume>109</volume><fpage>1117</fpage><lpage>1131</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2672.2010.04756.x</pub-id><pub-id pub-id-type="pmid">20522145</pub-id></element-citation></ref><ref id="B5-molecules-30-03552"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alves</surname><given-names>D.</given-names></name><name name-style="western"><surname>Cerqueira</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Pastrana</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Sillankorva</surname><given-names>S.</given-names></name></person-group><article-title>Entrapment of a Phage Cocktail and Cinnamaldehyde on Sodium Alginate Emulsion-Based Films to Fight Food Contamination by Escherichia Coli and Salmonella Enteritidis</article-title><source>Food Res. Int.</source><year>2020</year><volume>128</volume><fpage>108791</fpage><pub-id pub-id-type="doi">10.1016/j.foodres.2019.108791</pub-id><pub-id pub-id-type="pmid">31955758</pub-id></element-citation></ref><ref id="B6-molecules-30-03552"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hoelzer</surname><given-names>K.</given-names></name><name name-style="western"><surname>Moreno Switt</surname><given-names>A.I.</given-names></name><name name-style="western"><surname>Wiedmann</surname><given-names>M.</given-names></name><name name-style="western"><surname>Boor</surname><given-names>K.J.</given-names></name></person-group><article-title>Emerging Needs and Opportunities in Foodborne Disease Detection and Prevention: From Tools to People</article-title><source>Food Microbiol.</source><year>2018</year><volume>75</volume><fpage>65</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.fm.2017.07.006</pub-id><pub-id pub-id-type="pmid">30056965</pub-id></element-citation></ref><ref id="B7-molecules-30-03552"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Panda</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Buroni</surname><given-names>S.</given-names></name><name name-style="western"><surname>Swain</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Bonacorsi</surname><given-names>A.</given-names></name><name name-style="western"><surname>da Fonseca Amorim</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Kulshrestha</surname><given-names>M.</given-names></name><name name-style="western"><surname>da Silva</surname><given-names>L.C.N.</given-names></name><name name-style="western"><surname>Tiwari</surname><given-names>V.</given-names></name></person-group><article-title>Recent Advances to Combat ESKAPE Pathogens with Special Reference to Essential Oils</article-title><source>Front. Microbiol.</source><year>2022</year><volume>13</volume><elocation-id>1029098</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2022.1029098</pub-id><pub-id pub-id-type="pmid">36560948</pub-id><pub-id pub-id-type="pmcid">PMC9763703</pub-id></element-citation></ref><ref id="B8-molecules-30-03552"><label>8.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>WHO</collab></person-group><source>Antimicrobial Resistance: Global Report on Surveillance</source><publisher-name>World Health Organization</publisher-name><publisher-loc>Geneva, Switzerland</publisher-loc><year>2024</year></element-citation></ref><ref id="B9-molecules-30-03552"><label>9.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>FAO</collab><collab>WHO</collab></person-group><source>Food Control System Assessment Tool: Introduction and Glossary</source><series>Food Safety and Quality Series No. 7/1</series><publisher-name>World Health Organization</publisher-name><publisher-loc>Geneva, Switzerland</publisher-loc><year>2019</year><isbn>9789251316306</isbn></element-citation></ref><ref id="B10-molecules-30-03552"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oliveira</surname><given-names>A.</given-names></name><name name-style="western"><surname>Dias</surname><given-names>C.</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>R.</given-names></name><name name-style="western"><surname>Almeida</surname><given-names>C.</given-names></name><name name-style="western"><surname>Fuci&#241;os</surname><given-names>P.</given-names></name><name name-style="western"><surname>Sillankorva</surname><given-names>S.</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>H.</given-names></name></person-group><article-title>Paving the Way Forward: Escherichia Coli Bacteriophages in a One Health Approach</article-title><source>Crit. Rev. Microbiol.</source><year>2023</year><volume>50</volume><fpage>87</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1080/1040841X.2022.2161869</pub-id><pub-id pub-id-type="pmid">36608263</pub-id></element-citation></ref><ref id="B11-molecules-30-03552"><label>11.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Souza</surname><given-names>G.M.</given-names></name><name name-style="western"><surname>de Oliveira Vieira</surname><given-names>K.C.</given-names></name><name name-style="western"><surname>Naldi</surname><given-names>L.V.</given-names></name><name name-style="western"><surname>Pereira</surname><given-names>V.C.</given-names></name><name name-style="western"><surname>Winkelstroter</surname><given-names>L.K.</given-names></name></person-group><article-title>Green Synthesized Nanoparticles as a Promising Strategy for Controlling Microbial Biofilm</article-title><source>Nanotechnology for Advances in Medical Microbiology</source><publisher-name>Springer</publisher-name><publisher-loc>Singapore</publisher-loc><year>2021</year></element-citation></ref><ref id="B12-molecules-30-03552"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carstens</surname><given-names>C.K.</given-names></name><name name-style="western"><surname>Salazar</surname><given-names>J.K.</given-names></name><name name-style="western"><surname>Darkoh</surname><given-names>C.</given-names></name></person-group><article-title>Multistate Outbreaks of Foodborne Illness in the United States Associated With Fresh Produce From 2010 to 2017</article-title><source>Front. Microbiol.</source><year>2019</year><volume>10</volume><elocation-id>2667</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2019.02667</pub-id><pub-id pub-id-type="pmid">31824454</pub-id><pub-id pub-id-type="pmcid">PMC6883221</pub-id></element-citation></ref><ref id="B13-molecules-30-03552"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tack</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Ray</surname><given-names>L.</given-names></name><name name-style="western"><surname>Griffin</surname><given-names>P.M.</given-names></name><name name-style="western"><surname>Cieslak</surname><given-names>P.R.</given-names></name><name name-style="western"><surname>Dunn</surname><given-names>J.</given-names></name><name name-style="western"><surname>Rissman</surname><given-names>T.</given-names></name><name name-style="western"><surname>Jervis</surname><given-names>R.</given-names></name><name name-style="western"><surname>Lathrop</surname><given-names>S.</given-names></name><name name-style="western"><surname>Muse</surname><given-names>A.</given-names></name><name name-style="western"><surname>Duwell</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Preliminary Incidence and Trends of Infections with Pathogens Transmitted Commonly Through Food&#8212;Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2016&#8211;2019</article-title><source>MMWR Morb. Mortal. Wkly. Rep.</source><year>2020</year><volume>69</volume><fpage>509</fpage><lpage>514</lpage><pub-id pub-id-type="doi">10.15585/mmwr.mm6917a1</pub-id><pub-id pub-id-type="pmid">32352955</pub-id><pub-id pub-id-type="pmcid">PMC7206985</pub-id></element-citation></ref><ref id="B14-molecules-30-03552"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crowe</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Mahon</surname><given-names>B.E.</given-names></name><name name-style="western"><surname>Vieira</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>Gould</surname><given-names>L.H.</given-names></name></person-group><article-title>Vital Signs: Multistate Foodborne Outbreaks&#8212;United States, 2010&#8211;2014</article-title><source>MMWR Morb. Mortal. Wkly. Rep.</source><year>2015</year><volume>64</volume><fpage>1221</fpage><lpage>1225</lpage><pub-id pub-id-type="doi">10.15585/mmwr.mm6443a4</pub-id><pub-id pub-id-type="pmid">26540483</pub-id></element-citation></ref><ref id="B15-molecules-30-03552"><label>15.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>FAO</collab></person-group><source>FAO Guide to Ranking Food Safety Risks at the National Level</source><publisher-name>Food and Agriculture Organization of the United Nations</publisher-name><publisher-loc>Rome, Italy</publisher-loc><year>2020</year><isbn>9789251332825</isbn></element-citation></ref><ref id="B16-molecules-30-03552"><label>16.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Jim</surname><given-names>O.</given-names></name></person-group><source>Tackling Drug-Resistant Infections Globally: Final Report and Recommendations</source><publisher-name>AMR Review</publisher-name><publisher-loc>Sydney, Australia</publisher-loc><year>2016</year></element-citation></ref><ref id="B17-molecules-30-03552"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mah</surname><given-names>T.F.</given-names></name></person-group><article-title>Biofilm-Specific Antibiotic Resistance</article-title><source>Future Microbiol.</source><year>2012</year><volume>7</volume><fpage>1061</fpage><lpage>1072</lpage><pub-id pub-id-type="doi">10.2217/fmb.12.76</pub-id><pub-id pub-id-type="pmid">22953707</pub-id></element-citation></ref><ref id="B18-molecules-30-03552"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moreau-Marquis</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bomberger</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>G.G.</given-names></name><name name-style="western"><surname>Swiatecka-Urban</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ye</surname><given-names>S.</given-names></name><name name-style="western"><surname>O&#8217;TOole</surname><given-names>G.A.</given-names></name><name name-style="western"><surname>Stanton</surname><given-names>B.A.</given-names></name></person-group><article-title>The F508-CFTR Mutation Results in Increased Biofilm Formation by Pseudomonas Aeruginosa by Increasing Iron Availability</article-title><source>Am. J. Physiol. Lung Cell. Mol. Physiol.</source><year>2008</year><volume>295</volume><fpage>L25</fpage><lpage>L37</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00391.2007</pub-id><pub-id pub-id-type="pmid">18359885</pub-id><pub-id pub-id-type="pmcid">PMC2494796</pub-id></element-citation></ref><ref id="B19-molecules-30-03552"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bai</surname><given-names>X.</given-names></name><name name-style="western"><surname>Nakatsu</surname><given-names>C.H.</given-names></name><name name-style="western"><surname>Bhunia</surname><given-names>A.K.</given-names></name></person-group><article-title>Bacterial Biofilms and Their Implications in Pathogenesis and Food Safety</article-title><source>Foods</source><year>2021</year><volume>10</volume><elocation-id>2117</elocation-id><pub-id pub-id-type="doi">10.3390/foods10092117</pub-id><pub-id pub-id-type="pmid">34574227</pub-id><pub-id pub-id-type="pmcid">PMC8472614</pub-id></element-citation></ref><ref id="B20-molecules-30-03552"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lambert</surname><given-names>R.J.W.</given-names></name><name name-style="western"><surname>Skandamis</surname><given-names>P.N.</given-names></name><name name-style="western"><surname>Coote</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Nychas</surname><given-names>G.-J.E.</given-names></name></person-group><article-title>A Study of the Minimum Inhibitory Concentration and Mode of Action of Oregano Essential Oil, Thymol and Carvacrol</article-title><source>J. Appl. Microbiol.</source><year>2001</year><volume>91</volume><fpage>453</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2672.2001.01428.x</pub-id><pub-id pub-id-type="pmid">11556910</pub-id></element-citation></ref><ref id="B21-molecules-30-03552"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ultee</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bennik</surname><given-names>M.H.J.</given-names></name><name name-style="western"><surname>Moezelaar</surname><given-names>R.</given-names></name></person-group><article-title>The Phenolic Hydroxyl Group of Carvacrol Is Essential for Action against the Food-Borne Pathogen Bacillus Cereus</article-title><source>Appl. Environ. Microbiol.</source><year>2002</year><volume>68</volume><fpage>1561</fpage><lpage>1568</lpage><pub-id pub-id-type="doi">10.1128/AEM.68.4.1561-1568.2002</pub-id><pub-id pub-id-type="pmid">11916669</pub-id><pub-id pub-id-type="pmcid">PMC123826</pub-id></element-citation></ref><ref id="B22-molecules-30-03552"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chouhan</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>K.</given-names></name><name name-style="western"><surname>Guleria</surname><given-names>S.</given-names></name></person-group><article-title>Antimicrobial Activity of Some Essential Oils&#8212;Present Status and Future Perspectives</article-title><source>Medicines</source><year>2017</year><volume>4</volume><elocation-id>58</elocation-id><pub-id pub-id-type="doi">10.3390/medicines4030058</pub-id><pub-id pub-id-type="pmid">28930272</pub-id><pub-id pub-id-type="pmcid">PMC5622393</pub-id></element-citation></ref><ref id="B23-molecules-30-03552"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>D.</given-names></name></person-group><article-title>Potential of Phage Depolymerase for the Treatment of Bacterial Biofilms</article-title><source>Virulence</source><year>2023</year><volume>14</volume><fpage>2273567</fpage><pub-id pub-id-type="doi">10.1080/21505594.2023.2273567</pub-id><pub-id pub-id-type="pmid">37872768</pub-id><pub-id pub-id-type="pmcid">PMC10621286</pub-id></element-citation></ref><ref id="B24-molecules-30-03552"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wintachai</surname><given-names>P.</given-names></name><name name-style="western"><surname>Voravuthikunchai</surname><given-names>S.P.</given-names></name></person-group><article-title>Characterization of Novel Lytic Myoviridae Phage Infecting Multidrug-Resistant Acinetobacter Baumannii and Synergistic Antimicrobial Efficacy between Phage and Sacha Inchi Oil</article-title><source>Pharmaceuticals</source><year>2022</year><volume>15</volume><elocation-id>291</elocation-id><pub-id pub-id-type="doi">10.3390/ph15030291</pub-id><pub-id pub-id-type="pmid">35337089</pub-id><pub-id pub-id-type="pmcid">PMC8949666</pub-id></element-citation></ref><ref id="B25-molecules-30-03552"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Amarillas</surname><given-names>L.</given-names></name><name name-style="western"><surname>Rub&#237;-Rangel</surname><given-names>L.</given-names></name><name name-style="western"><surname>Chaidez</surname><given-names>C.</given-names></name><name name-style="western"><surname>Gonz&#225;lez-Robles</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lightbourn-Rojas</surname><given-names>L.</given-names></name><name name-style="western"><surname>Le&#243;n-F&#233;lix</surname><given-names>J.</given-names></name></person-group><article-title>Isolation and Characterization of PhiLLS, a Novel Phage with Potential Biocontrol Agent against Multidrug-Resistant Escherichia Coli</article-title><source>Front. Microbiol.</source><year>2017</year><volume>8</volume><elocation-id>1355</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2017.01355</pub-id><pub-id pub-id-type="pmid">28785246</pub-id><pub-id pub-id-type="pmcid">PMC5519627</pub-id></element-citation></ref><ref id="B26-molecules-30-03552"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Topka-Bielecka</surname><given-names>G.</given-names></name><name name-style="western"><surname>Dydecka</surname><given-names>A.</given-names></name><name name-style="western"><surname>Necel</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bloch</surname><given-names>S.</given-names></name><name name-style="western"><surname>Nejman-Fale&#324;czyk</surname><given-names>B.</given-names></name><name name-style="western"><surname>W&#281;grzyn</surname><given-names>G.</given-names></name><name name-style="western"><surname>W&#281;grzyn</surname><given-names>A.</given-names></name></person-group><article-title>Bacteriophage-Derived Depolymerases against Bacterial Biofilm</article-title><source>Antibiotics</source><year>2021</year><volume>10</volume><elocation-id>175</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics10020175</pub-id><pub-id pub-id-type="pmid">33578658</pub-id><pub-id pub-id-type="pmcid">PMC7916357</pub-id></element-citation></ref><ref id="B27-molecules-30-03552"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Amankwah</surname><given-names>S.</given-names></name><name name-style="western"><surname>Abdella</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kassa</surname><given-names>T.</given-names></name></person-group><article-title>Bacterial Biofilm Destruction: A Focused Review on the Recent Use of Phage-Based Strategies with Other Antibiofilm Agents</article-title><source>Nanotechnol. Sci. Appl.</source><year>2021</year><volume>14</volume><fpage>161</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.2147/NSA.S325594</pub-id><pub-id pub-id-type="pmid">34548785</pub-id><pub-id pub-id-type="pmcid">PMC8449863</pub-id></element-citation></ref><ref id="B28-molecules-30-03552"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pei</surname><given-names>R.</given-names></name><name name-style="western"><surname>Lamas-Samanamud</surname><given-names>G.R.</given-names></name></person-group><article-title>Inhibition of Biofilm Formation by T7 Bacteriophages Producing Quorum-Quenching Enzymes</article-title><source>Appl. Environ. Microbiol.</source><year>2014</year><volume>80</volume><fpage>5340</fpage><lpage>5348</lpage><pub-id pub-id-type="doi">10.1128/AEM.01434-14</pub-id><pub-id pub-id-type="pmid">24951790</pub-id><pub-id pub-id-type="pmcid">PMC4136088</pub-id></element-citation></ref><ref id="B29-molecules-30-03552"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ali</surname><given-names>S.</given-names></name><name name-style="western"><surname>Karaynir</surname><given-names>A.</given-names></name><name name-style="western"><surname>Do&#287;an</surname><given-names>H.S.</given-names></name><name name-style="western"><surname>Nachimuthu</surname><given-names>R.</given-names></name><name name-style="western"><surname>Badu</surname><given-names>K.</given-names></name><name name-style="western"><surname>Bozdo&#287;an</surname><given-names>B.</given-names></name></person-group><article-title>Degradation of Preformed Gram-Positive and Gram-Negative Bacterial Biofilms Using Disintegrated and Intact Phages</article-title><source>PHAGE</source><year>2025</year><volume>6</volume><fpage>20</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1089/phage.2024.0029</pub-id><pub-id pub-id-type="pmid">40351404</pub-id><pub-id pub-id-type="pmcid">PMC12059619</pub-id></element-citation></ref><ref id="B30-molecules-30-03552"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ni</surname><given-names>P.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Deng</surname><given-names>B.</given-names></name><name name-style="western"><surname>Jiu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Almeida</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>D.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S.</given-names></name></person-group><article-title>Combined Application of Bacteriophages and Carvacrol in the Control of Pseudomonas Syringae Pv. Actinidiae Planktonic and Biofilm Forms</article-title><source>Microorganisms</source><year>2020</year><volume>8</volume><elocation-id>837</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms8060837</pub-id><pub-id pub-id-type="pmid">32498472</pub-id><pub-id pub-id-type="pmcid">PMC7356356</pub-id></element-citation></ref><ref id="B31-molecules-30-03552"><label>31.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Ben Said</surname><given-names>M.</given-names></name><name name-style="western"><surname>Trabelsi</surname><given-names>D.</given-names></name><name name-style="western"><surname>Achouri</surname><given-names>F.</given-names></name><name name-style="western"><surname>Saad</surname><given-names>M.B.</given-names></name><name name-style="western"><surname>Bousselmi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ghrabi</surname><given-names>A.</given-names></name></person-group><article-title>Application of Bacteriophage and Essential Oil to Monitor Bacterial Biofilm Formation</article-title><source>Recent Advances in Environmental Science from the Euro-Mediterranean and Surrounding Regions</source><publisher-name>Springer</publisher-name><publisher-loc>Cham, Switzerland</publisher-loc><year>2018</year><fpage>273</fpage><lpage>274</lpage></element-citation></ref><ref id="B32-molecules-30-03552"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haney</surname><given-names>E.F.</given-names></name><name name-style="western"><surname>Trimble</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Hancock</surname><given-names>R.E.W.</given-names></name></person-group><article-title>Microtiter Plate Assays to Assess Antibiofilm Activity against Bacteria</article-title><source>Nat. Protoc.</source><year>2021</year><volume>16</volume><fpage>2615</fpage><lpage>2632</lpage><pub-id pub-id-type="doi">10.1038/s41596-021-00515-3</pub-id><pub-id pub-id-type="pmid">33911258</pub-id></element-citation></ref><ref id="B33-molecules-30-03552"><label>33.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Villalobos-delgado</surname><given-names>L.H.</given-names></name><name name-style="western"><surname>Caro</surname><given-names>I.</given-names></name><name name-style="western"><surname>Quinto</surname><given-names>E.J.</given-names></name><name name-style="western"><surname>Mateo</surname><given-names>J.</given-names></name></person-group><source>Natural Antimicrobial Agents to Improve Foods Shelf Life</source><publisher-name>Elsevier Inc.</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>2019</year><isbn>9780128171905</isbn></element-citation></ref><ref id="B34-molecules-30-03552"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alexander</surname><given-names>F.</given-names></name><name name-style="western"><surname>Agudelo</surname><given-names>G.</given-names></name><name name-style="western"><surname>Ospina</surname><given-names>J.N.</given-names></name><name name-style="western"><surname>Mary</surname><given-names>L.</given-names></name><name name-style="western"><surname>Pulido</surname><given-names>S.</given-names></name></person-group><article-title>Innovaciones En La Terapia Antimicrobiana Innovations in Antimicrobial Therapy</article-title><source>Nova</source><year>2020</year><volume>18</volume><fpage>9</fpage><lpage>25</lpage></element-citation></ref><ref id="B35-molecules-30-03552"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luna Guevara</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Luna Guevara</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Espinosa</surname><given-names>H.R.</given-names></name><name name-style="western"><surname>Abascal</surname><given-names>L.L.</given-names></name><name name-style="western"><surname>D&#237;az Gonz&#225;lez</surname><given-names>C.B.</given-names></name></person-group><article-title>Eficiencia de La Desinfecci&#243;n Con Aceites Esenciales y Ultrasonido Sobre Escherichia Coli Inoculada En Frutos de Tomate y El Impacto Sobre La Actividad Antioxidante</article-title><source>Rev. Argent. Microbiol.</source><year>2015</year><volume>47</volume><fpage>251</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1016/j.ram.2015.04.004</pub-id><pub-id pub-id-type="pmid">26323374</pub-id></element-citation></ref><ref id="B36-molecules-30-03552"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Cai</surname><given-names>P.</given-names></name></person-group><article-title>Application of Atomic Force Microscopy (AFM) to Study Bacterial Biofilms</article-title><source>Shengwu Gongcheng Xuebao/Chin. J. Biotechnol.</source><year>2017</year><volume>33</volume><fpage>1399</fpage><lpage>1410</lpage><pub-id pub-id-type="doi">10.13345/j.cjb.170190</pub-id><pub-id pub-id-type="pmid">28956391</pub-id></element-citation></ref><ref id="B37-molecules-30-03552"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Xue</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Y.</given-names></name></person-group><article-title>Advances in Biofilm Characterization: Utilizing Rheology and Atomic Force Microscopy in Foods and Related Fields</article-title><source>Adv. Compos. Hybrid. Mater.</source><year>2024</year><volume>7</volume><fpage>143</fpage><pub-id pub-id-type="doi">10.1007/s42114-024-00950-2</pub-id></element-citation></ref><ref id="B38-molecules-30-03552"><label>38.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Kropinski</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Mazzocco</surname><given-names>A.</given-names></name><name name-style="western"><surname>Waddell</surname><given-names>T.E.</given-names></name><name name-style="western"><surname>Lingohr</surname><given-names>E.</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>R.P.</given-names></name></person-group><article-title>Enumeration of Bacteriophages by Double Agar Overlay Plaque Assay</article-title><source>Bacteriophages: Methods and Protocols, Volume 1: Isolation, Characterization, and Interactions</source><person-group person-group-type="editor"><name name-style="western"><surname>Clokie</surname><given-names>M.R.J.</given-names></name><name name-style="western"><surname>Kropinski</surname><given-names>A.M.</given-names></name></person-group><publisher-name>Humana Press</publisher-name><publisher-loc>Totowa, NJ, USA</publisher-loc><year>2009</year><fpage>69</fpage><lpage>76</lpage><isbn>978-1-60327-164-6</isbn><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-1-60327-164-6_7</pub-id><pub-id pub-id-type="pmid">19066811</pub-id></element-citation></ref><ref id="B39-molecules-30-03552"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leh&#225;r</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zimmermann</surname><given-names>G.R.</given-names></name><name name-style="western"><surname>Krueger</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Molnar</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Ledell</surname><given-names>J.T.</given-names></name><name name-style="western"><surname>Heilbut</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Short</surname><given-names>G.F.</given-names></name><name name-style="western"><surname>Giusti</surname><given-names>L.C.</given-names></name><name name-style="western"><surname>Nolan</surname><given-names>G.P.</given-names></name><name name-style="western"><surname>Magid</surname><given-names>O.A.</given-names></name><etal/></person-group><article-title>Chemical Combination Effects Predict Connectivity in Biological Systems</article-title><source>Mol. Syst. Biol.</source><year>2007</year><volume>3</volume><elocation-id>80</elocation-id><pub-id pub-id-type="doi">10.1038/msb4100116</pub-id><pub-id pub-id-type="pmid">17332758</pub-id><pub-id pub-id-type="pmcid">PMC1828746</pub-id></element-citation></ref><ref id="B40-molecules-30-03552"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bliss</surname><given-names>C.I.</given-names></name></person-group><article-title>The Toxicity of Poisons Applied Jointly</article-title><source>Ann. Appl. Biol.</source><year>1939</year><volume>26</volume><fpage>585</fpage><lpage>615</lpage><pub-id pub-id-type="doi">10.1111/j.1744-7348.1939.tb06990.x</pub-id></element-citation></ref><ref id="B41-molecules-30-03552"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eaton</surname><given-names>P.</given-names></name><name name-style="western"><surname>Fernandes</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Pereira</surname><given-names>E.</given-names></name><name name-style="western"><surname>Pintado</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Xavier Malcata</surname><given-names>F.</given-names></name></person-group><article-title>Atomic Force Microscopy Study of the Antibacterial Effects of Chitosans on Escherichia Coli and Staphylococcus Aureus</article-title><source>Ultramicroscopy</source><year>2008</year><volume>108</volume><fpage>1128</fpage><lpage>1134</lpage><pub-id pub-id-type="doi">10.1016/j.ultramic.2008.04.015</pub-id><pub-id pub-id-type="pmid">18556125</pub-id></element-citation></ref><ref id="B42-molecules-30-03552"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perry</surname><given-names>C.C.</given-names></name><name name-style="western"><surname>Weatherly</surname><given-names>M.</given-names></name><name name-style="western"><surname>Beale</surname><given-names>T.</given-names></name><name name-style="western"><surname>Randriamahefa</surname><given-names>A.</given-names></name></person-group><article-title>Atomic Forcemicroscopy Study of the Antimicrobial Activity of Aqueous Garlic versus Ampicillin against Escherichia Coli and Staphylococcus Aureus</article-title><source>J. Sci. Food Agric.</source><year>2009</year><volume>89</volume><fpage>958</fpage><lpage>964</lpage><pub-id pub-id-type="doi">10.1002/jsfa.3538</pub-id></element-citation></ref><ref id="B43-molecules-30-03552"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pei</surname><given-names>Z.J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>C.</given-names></name><name name-style="western"><surname>Dai</surname><given-names>W.</given-names></name><name name-style="western"><surname>Lou</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Wan</surname><given-names>C.</given-names></name></person-group><article-title>The Anti-Biofilm Activity and Mechanism of Apigenin-7-O-Glucoside Against Staphylococcus Aureus and Escherichia Coli</article-title><source>Infect. Drug Resist.</source><year>2023</year><volume>16</volume><fpage>2129</fpage><lpage>2140</lpage><pub-id pub-id-type="doi">10.2147/IDR.S387157</pub-id><pub-id pub-id-type="pmid">37070126</pub-id><pub-id pub-id-type="pmcid">PMC10105580</pub-id></element-citation></ref><ref id="B44-molecules-30-03552"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>C.G.</given-names></name><name name-style="western"><surname>Green</surname><given-names>S.I.</given-names></name><name name-style="western"><surname>Min</surname><given-names>L.</given-names></name><name name-style="western"><surname>Clark</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Salazar</surname><given-names>K.C.</given-names></name><name name-style="western"><surname>Terwilliger</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Kaplan</surname><given-names>H.B.</given-names></name><name name-style="western"><surname>Trautner</surname><given-names>B.W.</given-names></name><name name-style="western"><surname>Ramig</surname><given-names>R.F.</given-names></name><name name-style="western"><surname>Maresso</surname><given-names>A.W.</given-names></name></person-group><article-title>Phage-Antibiotic Synergy Is Driven by a Unique Combination of Antibacterial Mechanism of Action and Stoichiometry</article-title><source>mBio</source><year>2020</year><volume>11</volume><fpage>e01462-20</fpage><pub-id pub-id-type="doi">10.1128/mbio.01462-20</pub-id><pub-id pub-id-type="pmid">32753497</pub-id><pub-id pub-id-type="pmcid">PMC7407087</pub-id></element-citation></ref><ref id="B45-molecules-30-03552"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alavi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Karimi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Salimikia</surname><given-names>I.</given-names></name></person-group><article-title>Phytosynthesis of Zinc Oxide Nanoparticles and Its Antibacterial, Antiquorum Sensing, Antimotility, and Antioxidant Capacities against Multidrug Resistant Bacteria</article-title><source>J. Ind. Eng. Chem.</source><year>2019</year><volume>72</volume><fpage>457</fpage><lpage>473</lpage><pub-id pub-id-type="doi">10.1016/j.jiec.2019.01.002</pub-id></element-citation></ref><ref id="B46-molecules-30-03552"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>AL-Dujaily</surname><given-names>A.H.</given-names></name><name name-style="western"><surname>Mahmood</surname><given-names>A.K.</given-names></name></person-group><article-title>Evaluation of Antibacterial and Antibiofilm Activity of Biogenic Silver Nanoparticles and Gentamicin Against Staphylococcus Aureus Isolated from Caprine Mastitis</article-title><source>Iraqi J. Vet. Med.</source><year>2022</year><volume>46</volume><fpage>10</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.30539/ijvm.v46i1.1309</pub-id></element-citation></ref><ref id="B47-molecules-30-03552"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mahmoudi-Qashqay</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zamani-Meymian</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Sadati</surname><given-names>S.J.</given-names></name></person-group><article-title>Improving Antibacterial Ability of Ti-Cu Thin Films with Co-Sputtering Method</article-title><source>Sci. Rep.</source><year>2023</year><volume>13</volume><elocation-id>16593</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-023-43875-4</pub-id><pub-id pub-id-type="pmid">37789153</pub-id><pub-id pub-id-type="pmcid">PMC10547835</pub-id></element-citation></ref><ref id="B48-molecules-30-03552"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Odds</surname><given-names>F.C.</given-names></name></person-group><article-title>Synergy, Antagonism, and What the Chequerboard Puts between Them</article-title><source>J. Antimicrob. Chemother.</source><year>2003</year><volume>52</volume><fpage>1</fpage><pub-id pub-id-type="doi">10.1093/jac/dkg301</pub-id><pub-id pub-id-type="pmid">12805255</pub-id></element-citation></ref><ref id="B49-molecules-30-03552"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khong</surname><given-names>E.</given-names></name><name name-style="western"><surname>Oh</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Jimenez</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>R.</given-names></name><name name-style="western"><surname>Dunham</surname><given-names>S.</given-names></name><name name-style="western"><surname>Monsibais</surname><given-names>A.</given-names></name><name name-style="western"><surname>Rhoads</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ghatbale</surname><given-names>P.</given-names></name><name name-style="western"><surname>Garcia</surname><given-names>A.</given-names></name><name name-style="western"><surname>Cobi&#225;n G&#252;emes</surname><given-names>A.G.</given-names></name><etal/></person-group><article-title>A Simple Solid Media Assay for Detection of Synergy between Bacteriophages and Antibiotics</article-title><source>Microbiol. Spectr.</source><year>2024</year><volume>12</volume><elocation-id>e0322123</elocation-id><pub-id pub-id-type="doi">10.1128/spectrum.03221-23</pub-id><pub-id pub-id-type="pmid">38526142</pub-id><pub-id pub-id-type="pmcid">PMC11064537</pub-id></element-citation></ref><ref id="B50-molecules-30-03552"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Val&#233;rio</surname><given-names>N.</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>C.</given-names></name><name name-style="western"><surname>Jesus</surname><given-names>V.</given-names></name><name name-style="western"><surname>Branco</surname><given-names>T.</given-names></name><name name-style="western"><surname>Pereira</surname><given-names>C.</given-names></name><name name-style="western"><surname>Moreirinha</surname><given-names>C.</given-names></name><name name-style="western"><surname>Almeida</surname><given-names>A.</given-names></name></person-group><article-title>Effects of Single and Combined Use of Bacteriophages and Antibiotics to Inactivate Escherichia Coli</article-title><source>Virus Res.</source><year>2017</year><volume>240</volume><fpage>8</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1016/j.virusres.2017.07.015</pub-id><pub-id pub-id-type="pmid">28746884</pub-id></element-citation></ref><ref id="B51-molecules-30-03552"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Azeredo</surname><given-names>J.</given-names></name><name name-style="western"><surname>Garc&#237;a</surname><given-names>P.</given-names></name><name name-style="western"><surname>Drulis-Kawa</surname><given-names>Z.</given-names></name></person-group><article-title>Targeting Biofilms Using Phages and Their Enzymes</article-title><source>Curr. Opin. Biotechnol.</source><year>2021</year><volume>68</volume><fpage>251</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1016/j.copbio.2021.02.002</pub-id><pub-id pub-id-type="pmid">33714050</pub-id></element-citation></ref><ref id="B52-molecules-30-03552"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knecht</surname><given-names>L.E.</given-names></name><name name-style="western"><surname>Veljkovic</surname><given-names>M.</given-names></name><name name-style="western"><surname>Fieseler</surname><given-names>L.</given-names></name></person-group><article-title>Diversity and Function of Phage Encoded Depolymerases</article-title><source>Front. Microbiol.</source><year>2020</year><volume>10</volume><elocation-id>2949</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2019.02949</pub-id><pub-id pub-id-type="pmid">31998258</pub-id><pub-id pub-id-type="pmcid">PMC6966330</pub-id></element-citation></ref><ref id="B53-molecules-30-03552"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Janesomboon</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sawaengwong</surname><given-names>T.</given-names></name><name name-style="western"><surname>Muangsombut</surname><given-names>V.</given-names></name><name name-style="western"><surname>Vanaporn</surname><given-names>M.</given-names></name><name name-style="western"><surname>Santanirand</surname><given-names>P.</given-names></name><name name-style="western"><surname>Kritsiriwuthinan</surname><given-names>K.</given-names></name><name name-style="western"><surname>Gundogdu</surname><given-names>O.</given-names></name><name name-style="western"><surname>Chantratita</surname><given-names>N.</given-names></name><name name-style="western"><surname>Nale</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Korbsrisate</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Synergistic Antibacterial Activity of Curcumin and Phage against Multidrug-Resistant Acinetobacter Baumannii</article-title><source>Sci. Rep.</source><year>2025</year><volume>15</volume><elocation-id>8959</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-025-94040-y</pub-id><pub-id pub-id-type="pmid">40089540</pub-id><pub-id pub-id-type="pmcid">PMC11910616</pub-id></element-citation></ref><ref id="B54-molecules-30-03552"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gunn</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bakaletz</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wozniak</surname><given-names>D.</given-names></name></person-group><article-title>What&#8217;s on the Outside Matters: The Role of the Extracellular Polymeric Substance of Gram-Negative Biofilms in Evading Host Immunity and as a Target for Therapeutic Intervention</article-title><source>J. Biol. Chem.</source><year>2016</year><volume>291</volume><fpage>12538</fpage><lpage>12546</lpage><pub-id pub-id-type="doi">10.1074/jbc.R115.707547</pub-id><pub-id pub-id-type="pmid">27129225</pub-id><pub-id pub-id-type="pmcid">PMC4933457</pub-id></element-citation></ref><ref id="B55-molecules-30-03552"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ruhal</surname><given-names>R.</given-names></name><name name-style="western"><surname>Kataria</surname><given-names>R.</given-names></name></person-group><article-title>Biofilm Patterns in Gram-Positive and Gram-Negative Bacteria</article-title><source>Microbiol. Res.</source><year>2021</year><volume>251</volume><elocation-id>126829</elocation-id><pub-id pub-id-type="doi">10.1016/j.micres.2021.126829</pub-id><pub-id pub-id-type="pmid">34332222</pub-id></element-citation></ref><ref id="B56-molecules-30-03552"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheeseman</surname><given-names>S.</given-names></name><name name-style="western"><surname>Shaw</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Vongsvivut</surname><given-names>J.</given-names></name><name name-style="western"><surname>Crawford</surname><given-names>R.</given-names></name><name name-style="western"><surname>Dupont</surname><given-names>M.</given-names></name><name name-style="western"><surname>Boyce</surname><given-names>K.</given-names></name><name name-style="western"><surname>Gangadoo</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bryant</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bryant</surname><given-names>G.</given-names></name><name name-style="western"><surname>Cozzolino</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Analysis of Pathogenic Bacterial and Yeast Biofilms Using the Combination of Synchrotron ATR-FTIR Microspectroscopy and Chemometric Approaches</article-title><source>Molecules</source><year>2021</year><volume>26</volume><elocation-id>3890</elocation-id><pub-id pub-id-type="doi">10.3390/molecules26133890</pub-id><pub-id pub-id-type="pmid">34202224</pub-id><pub-id pub-id-type="pmcid">PMC8271424</pub-id></element-citation></ref><ref id="B57-molecules-30-03552"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mahdhi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Leban</surname><given-names>N.</given-names></name><name name-style="western"><surname>Chakroun</surname><given-names>I.</given-names></name><name name-style="western"><surname>Chaouch</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Hafsa</surname><given-names>J.</given-names></name><name name-style="western"><surname>Fdhila</surname><given-names>K.</given-names></name><name name-style="western"><surname>Mahdouani</surname><given-names>K.</given-names></name><name name-style="western"><surname>Majdoub</surname><given-names>H.</given-names></name></person-group><article-title>Extracellular Polysaccharide Derived from Potential Probiotic Strain with Antioxidant and Antibacterial Activities as a Prebiotic Agent to Control Pathogenic Bacterial Biofilm Formation</article-title><source>Microb. Pathog.</source><year>2017</year><volume>109</volume><fpage>214</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1016/j.micpath.2017.05.046</pub-id><pub-id pub-id-type="pmid">28583888</pub-id></element-citation></ref><ref id="B58-molecules-30-03552"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harimawan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ting</surname><given-names>Y.P.</given-names></name></person-group><article-title>Investigation of Extracellular Polymeric Substances (EPS) Properties of P. Aeruginosa and B. Subtilis and Their Role in Bacterial Adhesion</article-title><source>Colloids Surf. B Biointerfaces</source><year>2016</year><volume>146</volume><fpage>459</fpage><lpage>467</lpage><pub-id pub-id-type="doi">10.1016/j.colsurfb.2016.06.039</pub-id><pub-id pub-id-type="pmid">27395039</pub-id></element-citation></ref><ref id="B59-molecules-30-03552"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Misba</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zaidi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>A.</given-names></name></person-group><article-title>A Comparison of Antibacterial and Antibiofilm Efficacy of Phenothiazinium Dyes between Gram Positive and Gram Negative Bacterial Biofilm</article-title><source>Photodiagnosis Photodyn. Ther.</source><year>2017</year><volume>18</volume><fpage>24</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1016/j.pdpdt.2017.01.177</pub-id><pub-id pub-id-type="pmid">28119141</pub-id></element-citation></ref><ref id="B60-molecules-30-03552"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sinha</surname><given-names>S.</given-names></name><name name-style="western"><surname>Choudhuri</surname><given-names>M.</given-names></name><name name-style="western"><surname>Basu</surname><given-names>T.</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>D.</given-names></name><name name-style="western"><surname>Datta</surname><given-names>A.</given-names></name></person-group><article-title>Decisive Role of Polymer-Bovine Serum Albumin Interactions in Biofilm Substrates on &#8220;Philicity&#8221; and Extracellular Polymeric Substances Composition</article-title><source>Langmuir</source><year>2022</year><volume>38</volume><fpage>1966</fpage><lpage>1976</lpage><pub-id pub-id-type="doi">10.1021/acs.langmuir.1c00187</pub-id><pub-id pub-id-type="pmid">35119288</pub-id></element-citation></ref><ref id="B61-molecules-30-03552"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fulaz</surname><given-names>S.</given-names></name><name name-style="western"><surname>Vitale</surname><given-names>S.</given-names></name><name name-style="western"><surname>Quinn</surname><given-names>L.</given-names></name><name name-style="western"><surname>Casey</surname><given-names>E.</given-names></name></person-group><article-title>Nanoparticle-Biofilm Interactions: The Role of the EPS Matrix</article-title><source>Trends Microbiol.</source><year>2019</year><volume>27</volume><fpage>915</fpage><lpage>926</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2019.07.004</pub-id><pub-id pub-id-type="pmid">31420126</pub-id></element-citation></ref><ref id="B62-molecules-30-03552"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pinto</surname><given-names>R.</given-names></name><name name-style="western"><surname>Soares</surname><given-names>F.</given-names></name><name name-style="western"><surname>Reis</surname><given-names>S.</given-names></name><name name-style="western"><surname>Nunes</surname><given-names>C.</given-names></name><name name-style="western"><surname>Van Dijck</surname><given-names>P.</given-names></name></person-group><article-title>Innovative Strategies Toward the Disassembly of the EPS Matrix in Bacterial Biofilms</article-title><source>Front. Microbiol.</source><year>2020</year><volume>11</volume><elocation-id>952</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2020.00952</pub-id><pub-id pub-id-type="pmid">32528433</pub-id><pub-id pub-id-type="pmcid">PMC7264105</pub-id></element-citation></ref><ref id="B63-molecules-30-03552"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kavanaugh</surname><given-names>J.</given-names></name><name name-style="western"><surname>Flack</surname><given-names>C.</given-names></name><name name-style="western"><surname>Lister</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ricker</surname><given-names>E.</given-names></name><name name-style="western"><surname>Ibberson</surname><given-names>C.</given-names></name><name name-style="western"><surname>Jenul</surname><given-names>C.</given-names></name><name name-style="western"><surname>Moormeier</surname><given-names>D.</given-names></name><name name-style="western"><surname>Delmain</surname><given-names>E.</given-names></name><name name-style="western"><surname>Bayles</surname><given-names>K.</given-names></name><name name-style="western"><surname>Horswill</surname><given-names>A.</given-names></name></person-group><article-title>Identification of Extracellular DNA-Binding Proteins in the Biofilm Matrix</article-title><source>mBio</source><year>2019</year><volume>10</volume><fpage>e01137-19</fpage><pub-id pub-id-type="doi">10.1128/mBio.01137-19</pub-id><pub-id pub-id-type="pmid">31239382</pub-id><pub-id pub-id-type="pmcid">PMC6593408</pub-id></element-citation></ref><ref id="B64-molecules-30-03552"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karygianni</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ren</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Koo</surname><given-names>H.</given-names></name><name name-style="western"><surname>Thurnheer</surname><given-names>T.</given-names></name></person-group><article-title>Biofilm Matrixome: Extracellular Components in Structured Microbial Communities</article-title><source>Trends Microbiol.</source><year>2020</year><volume>28</volume><fpage>668</fpage><lpage>681</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2020.03.016</pub-id><pub-id pub-id-type="pmid">32663461</pub-id></element-citation></ref><ref id="B65-molecules-30-03552"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tomlinson</surname><given-names>K.</given-names></name><name name-style="western"><surname>Lung</surname><given-names>T.W.F.</given-names></name><name name-style="western"><surname>Dach</surname><given-names>F.</given-names></name><name name-style="western"><surname>Annavajhala</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gabryszewski</surname><given-names>S.</given-names></name><name name-style="western"><surname>Groves</surname><given-names>R.</given-names></name><name name-style="western"><surname>Drikic</surname><given-names>M.</given-names></name><name name-style="western"><surname>Francoeur</surname><given-names>N.</given-names></name><name name-style="western"><surname>Sridhar</surname><given-names>S.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Staphylococcus Aureus Induces an Itaconate-Dominated Immunometabolic Response That Drives Biofilm Formation</article-title><source>Nat. Commun.</source><year>2021</year><volume>12</volume><fpage>1399</fpage><pub-id pub-id-type="doi">10.1038/s41467-021-21718-y</pub-id><pub-id pub-id-type="pmid">33658521</pub-id><pub-id pub-id-type="pmcid">PMC7930111</pub-id></element-citation></ref><ref id="B66-molecules-30-03552"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salim</surname><given-names>S.</given-names></name><name name-style="western"><surname>Jadoon</surname><given-names>V.</given-names></name><name name-style="western"><surname>Batool</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ali</surname><given-names>I.</given-names></name><name name-style="western"><surname>Irshad</surname><given-names>U.</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>R.</given-names></name><name name-style="western"><surname>Qayum</surname><given-names>S.</given-names></name><name name-style="western"><surname>Noor</surname><given-names>A.</given-names></name><name name-style="western"><surname>Naqvi</surname><given-names>T.</given-names></name></person-group><article-title>A DNase from Halophilic Bacterium Bacillus Pacificus Targets Two Notorious Biofilms of Pseudomonas Aeruginosa PAO1 and Staphylococcus Aureus</article-title><source>Biocatal. Agric. Biotechnol.</source><year>2025</year><volume>64</volume><elocation-id>103515</elocation-id><pub-id pub-id-type="doi">10.1016/j.bcab.2025.103515</pub-id></element-citation></ref><ref id="B67-molecules-30-03552"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bai</surname><given-names>X.</given-names></name><name name-style="western"><surname>Shen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>T.</given-names></name><name name-style="western"><surname>Meng</surname><given-names>R.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Deng</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>N.</given-names></name></person-group><article-title>Anti-Biofilm Activity of Biochanin A against Staphylococcus Aureus</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2022</year><volume>107</volume><fpage>867</fpage><lpage>879</lpage><pub-id pub-id-type="doi">10.1007/s00253-022-12350-x</pub-id><pub-id pub-id-type="pmid">36585511</pub-id></element-citation></ref><ref id="B68-molecules-30-03552"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gupta</surname><given-names>A.</given-names></name><name name-style="western"><surname>Guptasarma</surname><given-names>P.E.</given-names></name></person-group><article-title>Coli Cells Advance into Phase-Separated (Biofilm-Simulating) Extracellular Polymeric Substance Containing DNA, HU, and Lipopolysaccharide</article-title><source>J. Bacteriol.</source><year>2024</year><volume>206</volume><fpage>e0030924</fpage><pub-id pub-id-type="doi">10.1128/jb.00309-24</pub-id><pub-id pub-id-type="pmid">39445815</pub-id><pub-id pub-id-type="pmcid">PMC11580401</pub-id></element-citation></ref><ref id="B69-molecules-30-03552"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Oh</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S.</given-names></name></person-group><article-title>Released Exopolysaccharide (r-EPS) Produced from Probiotic Bacteria Reduce Biofilm Formation of Enterohemorrhagic Escherichia Coli O157:H7</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2009</year><volume>379</volume><fpage>324</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2008.12.053</pub-id><pub-id pub-id-type="pmid">19103165</pub-id></element-citation></ref><ref id="B70-molecules-30-03552"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Teppen</surname><given-names>B.</given-names></name><name name-style="western"><surname>Boyd</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Tiedje</surname><given-names>J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>H.</given-names></name></person-group><article-title>Tetracycline Accumulation in Biofilms Enhances the Selection Pressure on Escherichia Coli for Expression of Antibiotic Resistance</article-title><source>Sci. Total Environ.</source><year>2022</year><volume>857</volume><fpage>159441</fpage><pub-id pub-id-type="doi">10.1016/j.scitotenv.2022.159441</pub-id><pub-id pub-id-type="pmid">36252660</pub-id></element-citation></ref><ref id="B71-molecules-30-03552"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>D.W.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Park</surname><given-names>J.H.</given-names></name></person-group><article-title>Thymol and Eugenol in Essential Oils Enhance Phage Endolysin LysECP26-Mediated Cell Wall Disruption of Escherichia Coli O157:H7</article-title><source>Korean J. Food Sci. Technol.</source><year>2021</year><volume>53</volume><fpage>819</fpage><lpage>822</lpage><pub-id pub-id-type="doi">10.9721/KJFST.2021.53.6.819</pub-id></element-citation></ref><ref id="B72-molecules-30-03552"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>D.W.</given-names></name><name name-style="western"><surname>Park</surname><given-names>J.H.</given-names></name></person-group><article-title>Characterization of a Novel Phage Depolymerase Specific to Escherichia Coli O157:H7 and Biofilm Control on Abiotic Surfaces</article-title><source>J. Microbiol.</source><year>2021</year><volume>59</volume><fpage>1002</fpage><lpage>1009</lpage><pub-id pub-id-type="doi">10.1007/s12275-021-1413-0</pub-id><pub-id pub-id-type="pmid">34613607</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="molecules-30-03552-f001" orientation="portrait"><label>Figure 1</label><caption><p>Viability of bacteriophage phiLLS after incubation with 4 mg/mL oregano essential oil (OEO) in a soft-agar overlay assay (10<sup>&#8722;4</sup> dilution). The presence of numerous, well-formed plaques (titer 1.8 &#215; 10<sup>9</sup> PFU/mL) indicates full retention of infectivity, with no reduction in plaque count or morphology compared to OEO-free controls.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-03552-g001.jpg"/></fig><fig position="float" id="molecules-30-03552-f002" orientation="portrait"><label>Figure 2</label><caption><p>Antimicrobial effects on bacterial growth kinetics and Bliss synergy analysis. (<bold>A</bold>) Growth kinetics of foodborne pathogens under different treatments: control (blue), oregano essential oil (OEO, orange), bacteriophage phiLLS (green), and OEO + phiLLS (red). Curves represent mean &#177; SD (n = 3). Asterisks indicate statistically significant differences compared to the untreated control (* <italic toggle="yes">p</italic> &lt; 0.05, *** <italic toggle="yes">p</italic> &lt; 0.001; one-way ANOVA with Tukey&#8217;s HSD), assessed at 9 h. (<bold>B</bold>) Bliss synergy index (%) calculated from the growth kinetics data. A dashed vertical line marks the 10% synergy threshold. Dark-grey bars denote additive interactions (&#8804;10%), and the green bar indicates the only synergistic case observed in growth kinetics (<italic toggle="yes">E. coli</italic> BALL 1119, 10.8%). Exact Bliss values are labeled at the end of each bar.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-03552-g002.jpg"/></fig><fig position="float" id="molecules-30-03552-f003" orientation="portrait"><label>Figure 3</label><caption><p>Biofilm assays: biomass (CV) and metabolic activity (TTC). Heatmaps showing percent reduction in biomass (CV) and metabolic activity (TTC) across all bacteria&#8211;treatment combinations (<bold>A</bold>). The significance maps (<bold>B</bold>) show which treatments produced statistically significant inhibition (green = significant, red = not significant) for each bacteria&#8211;treatment combination.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-03552-g003.jpg"/></fig><fig position="float" id="molecules-30-03552-f004" orientation="portrait"><label>Figure 4</label><caption><p>Synergy Assessment of OEO + phage. The Highest-Single-Agent (HSA) and Bliss independence models were applied to the OEO + phage phiLLS combination across six food-borne pathogens. <italic toggle="yes">&#916;Bliss and &#916;HSA</italic> panels: grey = additive (|&#916;| &#8804; 10%), green = synergistic (&#916; &gt; 10%), red = antagonistic (&#916; &lt; &#8211;10%). Dashed lines at &#177;10% denote thresholds.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-03552-g004.jpg"/></fig><fig position="float" id="molecules-30-03552-f005" orientation="portrait"><label>Figure 5</label><caption><p>Representative AFM topographical analysis of <italic toggle="yes">S. aureus</italic> biofilms under different treatments. Biofilms were imaged in tapping mode under four conditions: untreated control, oregano essential oil (OEO, 2 mg/mL), bacteriophage phiLLS, and combined phiLLS + OEO. (<bold>A</bold>) Topographic error signal images (scan sizes: 20 &#181;m &#215; 20 &#181;m and 40 &#181;m &#215; 40 &#181;m) displaying overall surface texture and microcolony arrangement for each treatment. (<bold>B</bold>) Corresponding height maps (20 &#181;m &#215; 20 &#181;m) with a continuous color gradient (&#8722;200 to +200 nm), and color bars indicating minimum (black/green arrow), midpoint (brown/magenta arrow), and maximum (white/blue arrow) elevations; lateral scale bars = 1 &#181;m. (<bold>C</bold>) Three-dimensional surface renderings of the same 20 &#181;m &#215; 20 &#181;m areas, illustrating treatment-dependent changes in biofilm morphology. Control biofilms exhibit dense mounds and channels; OEO flattens and smooths the surface; phiLLS creates localized pits and erosive features; phiLLS + OEO produces pronounced valleys and sharp peaks, reflecting synergistic disruption of the extracellular matrix. Color gradients indicate surface elevation (nm), with white tones corresponding to the highest points and black to the deepest.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-03552-g005.jpg"/></fig><fig position="float" id="molecules-30-03552-f006" orientation="portrait"><label>Figure 6</label><caption><p>Statistical analysis of <italic toggle="yes">S. aureus</italic> biofilm morphology under four treatments (Control+, OEO, phiLLS, phiLLS + OEO) using AFM-derived surface parameters. (<bold>A</bold>) Boxplots of surface roughness (R<sub>a</sub>) by treatment: OEO and phiLLS + OEO tend to increase median R<sub>a</sub> relative to Control+, while phiLLS alone shows reduced R<sub>a</sub>; not pairwise differences remained significant after Bonferroni correction. (<bold>B</bold>) PCA biplot of all samples (PC1 vs. PC2), with points colored by treatment. PC1 (driven primarily by Rz and R<sub>a</sub>) separates untreated controls (low PC1, high PC2) from phage and combination treatments (positive PC1), indicating greater surface disruption. (<bold>C</bold>) Mean Silhouette scores for each treatment group, quantifying clustering cohesion and separation: Control+ exhibits the highest cohesion, OEO the lowest, and phiLLS + OEO intermediate. Together, these multivariate analyses indicate that phiLLS + OEO produces the most consistent disruption of the EPS matrix, followed by phiLLS alone, whereas untreated biofilms remain tightly clustered.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-03552-g006.jpg"/></fig><fig position="float" id="molecules-30-03552-f007" orientation="portrait"><label>Figure 7</label><caption><p>AFM topographical comparison of <italic toggle="yes">Escherichia coli</italic> BALL1119 biofilms under different treatments. (<bold>A</bold>) Two-dimensional forward scan height images (20 &#181;m &#215; 20 &#181;m) for Control (untreated), OEO (oregano essential oil), phiLLS (bacteriophage phiLLS), and combined OEO + phiLLS. Each panel displays cell microcolonies and EPS distribution in false-color height. (<bold>B</bold>) Corresponding 2D height maps with color scales (nm) indicating z-range; lateral axes in &#181;m and 1 &#181;m scale bar. Arrows on the scale bars mark the minimum (green), midpoint (magenta), and maximum (blue) heights. (<bold>C</bold>) Three-dimensional reconstructions of the same 20 &#181;m &#215; 20 &#181;m areas, illustrating surface morphology and roughness differences. Control exhibits mature &#8220;mounds&#8221; and channels; OEO shows a flattened and rougher surface; phiLLS displays localized erosion and pits; OEO + phiLLS reveals deep valleys and sharp peaks. Treatment abbreviations: OEO, oregano essential oil; phiLLS, bacteriophage phiLLS.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-03552-g007.jpg"/></fig><fig position="float" id="molecules-30-03552-f008" orientation="portrait"><label>Figure 8</label><caption><p>Average surface roughness (Ra, nm) &#177;&#8201; SD of <italic toggle="yes">Escherichia coli BALL1119</italic> biofilms after four treatments: untreated Control+ biofilm, oregano essential oil (OEO), OEO combined with phage phiLLS (OEO + phiLLS), and phage phiLLS alone. Bars represent arithmetic means of three biological replicates; black dots show individual replicate values. Error bars denote standard deviation. One-way ANOVA followed by Tukey&#8217;s multiple comparison test was used to evaluate differences among treatments. * <italic toggle="yes">p</italic> &lt; 0.05 versus Control; ** <italic toggle="yes">p</italic> &lt; 0.001 versus all other groups.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-03552-g008.jpg"/></fig><table-wrap position="float" id="molecules-30-03552-t001" orientation="portrait"><object-id pub-id-type="pii">molecules-30-03552-t001_Table 1</object-id><label>Table 1</label><caption><p>GC&#8211;MS chemical composition of <italic toggle="yes">Lippia graveolens</italic> essential oil.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Chemical Class</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">RT (min)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">R-Match</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">% Composition</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#945;-Pinene</td><td align="center" valign="middle" rowspan="1" colspan="1">Monoterpene hydrocarbons</td><td align="center" valign="middle" rowspan="1" colspan="1">3.906</td><td align="center" valign="middle" rowspan="1" colspan="1">849</td><td align="center" valign="middle" rowspan="1" colspan="1">0.870</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#946;-Myrcene</td><td align="center" valign="middle" rowspan="1" colspan="1">Monoterpene hydrocarbons</td><td align="center" valign="middle" rowspan="1" colspan="1">4.196</td><td align="center" valign="middle" rowspan="1" colspan="1">841</td><td align="center" valign="middle" rowspan="1" colspan="1">1.750</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">p-Cymene</td><td align="center" valign="middle" rowspan="1" colspan="1">Monoterpene hydrocarbons</td><td align="center" valign="middle" rowspan="1" colspan="1">4.364</td><td align="center" valign="middle" rowspan="1" colspan="1">816</td><td align="center" valign="middle" rowspan="1" colspan="1">28.616</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#947;-Terpinene</td><td align="center" valign="middle" rowspan="1" colspan="1">Monoterpene hydrocarbons</td><td align="center" valign="middle" rowspan="1" colspan="1">4.589</td><td align="center" valign="middle" rowspan="1" colspan="1">798</td><td align="center" valign="middle" rowspan="1" colspan="1">2.885</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Terpinen-4-ol</td><td align="center" valign="middle" rowspan="1" colspan="1">Oxygenated monoterpenes</td><td align="center" valign="middle" rowspan="1" colspan="1">5.657</td><td align="center" valign="middle" rowspan="1" colspan="1">717</td><td align="center" valign="middle" rowspan="1" colspan="1">0.739</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Methylthymol</td><td align="center" valign="middle" rowspan="1" colspan="1">Phenolic derivatives/esters</td><td align="center" valign="middle" rowspan="1" colspan="1">5.926</td><td align="center" valign="middle" rowspan="1" colspan="1">910</td><td align="center" valign="middle" rowspan="1" colspan="1">0.295</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Isothymol methyl ester</td><td align="center" valign="middle" rowspan="1" colspan="1">Phenolic derivatives/esters</td><td align="center" valign="middle" rowspan="1" colspan="1">6.006</td><td align="center" valign="middle" rowspan="1" colspan="1">915</td><td align="center" valign="middle" rowspan="1" colspan="1">0.198</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Thymol</td><td align="center" valign="middle" rowspan="1" colspan="1">Phenolic monoterpenes</td><td align="center" valign="middle" rowspan="1" colspan="1">6.865</td><td align="center" valign="middle" rowspan="1" colspan="1">750</td><td align="center" valign="middle" rowspan="1" colspan="1">0.174</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Carvacrol</td><td align="center" valign="middle" rowspan="1" colspan="1">Phenolic monoterpenes</td><td align="center" valign="middle" rowspan="1" colspan="1">6.520</td><td align="center" valign="middle" rowspan="1" colspan="1">750</td><td align="center" valign="middle" rowspan="1" colspan="1">58.897</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Caryophyllene</td><td align="center" valign="middle" rowspan="1" colspan="1">Sesquiterpene hydrocarbons</td><td align="center" valign="middle" rowspan="1" colspan="1">7.350</td><td align="center" valign="middle" rowspan="1" colspan="1">783</td><td align="center" valign="middle" rowspan="1" colspan="1">2.593</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Humulene</td><td align="center" valign="middle" rowspan="1" colspan="1">Sesquiterpene hydrocarbons</td><td align="center" valign="middle" rowspan="1" colspan="1">7.615</td><td align="center" valign="middle" rowspan="1" colspan="1">700</td><td align="center" valign="middle" rowspan="1" colspan="1">2.065</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Aromadendrene</td><td align="center" valign="middle" rowspan="1" colspan="1">Sesquiterpene hydrocarbons</td><td align="center" valign="middle" rowspan="1" colspan="1">7.831</td><td align="center" valign="middle" rowspan="1" colspan="1">846</td><td align="center" valign="middle" rowspan="1" colspan="1">0.323</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Caryophyllene oxide</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oxygenated sesquiterpenes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.702</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">843</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.597</td></tr></tbody></table><table-wrap-foot><fn><p>All identifications were tentative and based on mass-spectral matching to the NIST 2011b library using Agilent MS WorkStation software (v. 7.0.1). Relative amounts were determined by peak-area normalization without correction factors. Most of the identified compounds were monoterpenes (93.3%), dominated by phenolic monoterpenes such as carvacrol (58.90%) and p-cymene (28.62%), followed by &#947;-terpinene (2.89%). Sesquiterpenes accounted for 5.3% of the composition, primarily caryophyllene (2.59%) and humulene (2.07%), while oxygenated compounds such as terpinen-4-ol (0.73%) were present in minor amounts (&lt;1%).</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="molecules-30-03552-t002" orientation="portrait"><object-id pub-id-type="pii">molecules-30-03552-t002_Table 2</object-id><label>Table 2</label><caption><p>Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of oregano essential oil (OEO) against six bacterial strains. OEO was tested at concentrations from 4.0 to 0.025 mg/mL. Symbols: (&#8211;) indicates no bacterial growth; (+) indicates bacterial growth.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">48 h</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">OEO<break/>2 mg/mL</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">OEO<break/>1 mg/mL</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">OEO<break/>0.5 mg/mL</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">OEO<break/>0.25 mg/mL</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">E. coli BALL</italic> 1119</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td><td align="center" valign="middle" rowspan="1" colspan="1">+</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">L. monocytogenes</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">
+
</td><td align="center" valign="middle" rowspan="1" colspan="1">
+
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Salmonella</italic> spp.</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">
+
</td><td align="center" valign="middle" rowspan="1" colspan="1">
+
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">S. aureus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">
+
</td><td align="center" valign="middle" rowspan="1" colspan="1">
+
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">E. coli</italic>
O157:H7
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">
+
</td><td align="center" valign="middle" rowspan="1" colspan="1">
+
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">B. cereus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
+
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
+
</td></tr></tbody></table></table-wrap></floats-group></article></pmc-articleset>